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1. Introduction 
Enzymes so called (Enz’-a-ai-am) are biologically active protein molecules responsible of 
biochemical reactions in the bacteria, cells and organs. Enzymes regulate the rates of 
biochemical reactions to maintain the metabolism to keep active physiological actions in the 
body. High enzyme activities or high rates of reactions cause higher product formation or 
deposits to initiate disease. Drugs are used as enzyme competitors to normalize the 
reactions to correct disease. Most of diseases are cured by ‘enzyme inhibition’. Enzyme 
inhibition can be three types: competitive, non-competitive, and uncompetitive. Enzyme 
inhibition also provides a kind of defense in cells by regulation of metabolism to inhibit or 
stimulate the biochemical processes. Most of the drugs undergo detoxification and 
biotransformation in liver to regenerate or formation of new hepatocytes and Kupffer cells. 
Major biochemical events in liver regeneration are regulated by enzymes in energy 
metabolism, growth factors and cytokine molecules. 
Present chapter describes an example of liver cell enzyme battery to regulate the carbohydrate, 
lipid and protein metabolism in liver cells, mainly hepatocytes and Kupffer cells in the light of 
liver damage due to amoebic liver abscess and role of enzyme inhibition in liver regeneration 
by 2’-nitroimidazole. Liver damage by amoeba is manifested by elevated enzymes in cells. As 
a result, two major clinical manifestations of Entamoeba histolytica infection are amoebic colitis 
and amoebic liver abscesses. To cure amoebic liver abscess, liver regeneration and amoebic 
killing by 2’-nitroimidazole therapy is routine in clinical practice. 2’-nitroimidazole acts in liver 
to perform enzyme inhibition at the level of carbohydrate, lipid, and protein metabolic 
regulatory steps. Earlier, nitroimidazole derivatives were considered drug of choice in 
treatment of hepatic hypoxia (low oxygen) conditions in parasitic infections, cancer and 
recently nitroimidazole derivatives are emerging as hypoxia markers and radiosensitizers in 
tumor treatment [Sharma 2001, Sharma 2011a, 2011b].  
Since 1960, hepatocytes were investigated rich in major enzymes regulating the energy 
metabolism located in cytoplasm and mitochondria for glycolysis, TCA cycle while drug 
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metabolizing and redox enzymes are located in lysosomes and microsomes. Other enzymes 
also participate in defense processes such as respiratory burst, HMP shunt, oxygenase 
pathways and inflammatory cytokines. Present chapter reviews the ongoing developments 
with clear and complete information on action of new nitroimidazole derivatives as ‘enzyme 
inhibitors’ in liver selective cytotoxicity, oxygen depletion, hepatocellular DNA and enzyme 
normalization before enzyme can be used in hypoxia monitoring and therapy [Sharma, 
2011b]. The paucity of information on nitroimidazole-liver tissue interaction is poor and 
available data of initial sequential biochemical changes in liver cells is scanty which further 
leads to detectable hypoxia [Sharma 2011a, 2011b]. It is believed that initially enzyme 
regulated glucose and calcium hemostasis are the primary targets of hepatic hypoxia 
followed by enzyme regulated induced metabolic integrity loss leads to apoptosis, 
regulatory failure in glycolytic, TCA cycle, gluconeogenesis and Ca++ mediated cAMP 
related biodegradation of molecules [Sharma et al.2011c]. 
The present chapter focuses on hepatic enzyme inhibition by nitroimidazole at different 
levels of energy metabolism, respiratory burst and drug metabolizing enzymes. In following 
section, a molecular basis of enzyme inhibition and hepatocellular hypoxia and dysfunction 
criteria is described in detail. In following section, regulatory behavior of rate limiting 
enzymes of glycolysis, TCA cycle, phagocytosis is described with examples: glucokinase, 
phosphofructokinase, pyruvate kinase, lactate dehydrogenase, NADPH cytochrome P450 
reductase, phosphodieaterase, lysosomal enzymes in serum, liver biopsy samples. In next 
section, role of enzymes in liver abscess is described.  
1.1 Enzymes in liver abscess 
Entamoeba histolytica is a human-specific pathogen and reproducible animal models of 
intestinal amoebiasis have proved elusive to describe interaction between E. histolytica and 
liver cells. The most common extraintestinal manifestation of disease is amoebic liver-
abscess. Amoebic liver-abscesses arise from haematogenous spread (probably via the portal 
circulation) of amoebic trophozoites that have breached the colonic mucosa.[Thompson et 
al. 1985, Abuabara et al. 1982, Shandera et al. 1998, Barnes et al. 1987, Adams 1977, Lancet 
2003]. Effective nitroimidazole treatment and rapid diagnosis showed the mortality rates to 
1–3%. Entamoeba histolytica trophozoites can lyse neutrophils in vitro, causing them to release 
toxic substance killer enzymes such as superoxide dismutases, collagenases, elastases and 
cathepsins [Jarumilinta et al. 1964, Guerrant et al. 1981]. On these lines, author proposed a 
‘Hepatocellular dysfunction criteria’ to make systematic observations in abscess 
development and step by step method of medical/surgical intervention [Sharma et al.2011]. 
In previous reports, patient symptoms, leucocytosis without eosinophilia, mild anaemia, 
raised concentrations of alkaline phosphatase, and a high rate of erythrocyte sedimentation 
were the most common laboratory findings.[ Thompson et al. 1985, Abuabara et al. 1982, 
Shandera et al. 1998, Barnes et al. 1987, Adams 1977, Lancet 2003]. 
Amoeba cause amoebic liver abscesses, which are circumscribed regions of dead 
hepatocytes, liquefied cells and cellular debris surrounded by a rim of connective tissue, 
some inflammatory cells and few amoebic trophozoites [Sharma et al. 2011]. The adjacent 
liver parenchyma is usually completely normal. At same sites in liver so called ‘acini’ fixed 
sinusoidal phagocytic cells (Kupffer cells) provide defense against any bacteria, virus or 
foreign drug. Kupffer cells have two intracellular structures filled with enzymes: lysosomes 
(Lai-zo-somes) and microsomes (Mai-kro-zomes). Lysososmal bags filled with a large 
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number of lysosomal enzymes acting as destroyers actually lyse and digest the bacteria, 
virus and toxicants. Microsomal enzymes are active in detoxification of drugs or drug 
biotransformaton to interact (stimulation or inhibition of enzymes) with metabolic 
regulation in liver cells. Let us introduce a bit of enzymes in liver cells performing different 
metabolic regulatory functions in following description. Abscesses occupying large areas of 
the liver can be cured without drainage, and even by one single dose of 
nitroimidazole.[Powell et al. 1969, Lasserre et al. 1983, Akgun et al. 1999]. Today, role of 
ultrasound or percutaneous therapeutic aspiration guided by CT in the treatment of 
uncomplicated amoebic liver-abscess by surgical drainage is controversial.  
 
Enzyme Amoeba Hepatocyte Kupffer cell 
Glucose 6 Pase 
Glucose 6 PDH 
Phoshogluconate DH 
Phosphofructokinase 
Aldolase 
Pyruvate kinase 
Pyruvate DH 
LDH 
Citrate Synthase 
Isocitrate DH 
Succinate DH 
Malate DH 
Cytochrome C Oxidase 
NADPH Cyt C Reducatase 
NADH Oxidase 
Tyrosine Aminotransferase 
Aniline Hydroxylase 
Aminopyrine demethylase 
Acid DNAase 
Glutathione Reductase 
Peroxidase 
Catalase 
Superoxide dismutase 
Guanase 
Adinosine Deaminase 
Leucine aminopeptidase 
Ca++ ATPase 
5’ Nucleotidase 
Acid Lipase 
Acid Phosphatase 
Alkaline Phosphatase 
Beta glucuronidase
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Source: Sharma R. Effect of Nitroimidazole on isolated liver cells in development of amoebic liver 
abscess. Ph.D dissertation submitted to Indian Institute of Technology, Delhi, 1995. 
Table 1. Carbohydrate metabolizing enzymes in amoeba, hepatocytes and Kupffer cells. 
Abundance of enzyme activities in cells are shown. Comparative enzyme database of 
amoeba and isolated liver cells is shown and sketched in Figures 3,5, and 6. Strengths of 
different enzyme activities in amoeba, liver cells are shown as weak(+), moderate(++), 
high(+++), extreme(++++ or more). 
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Characterization of enzymes in amoeba has been a long time quest to explore the possibility of 
amebic enzyme inhibition by new drugs in drug discovery. Several antiamoebic drugs are in 
market as potent enzyme inhibitors since last four decades. Author proposed a comparative 
enzyme database of amoeba and hepatocellular cells in culture (see Table 1 and Figure 1). Of 
specific mention, cysteine proteinase enzymes are secreted in large quantities by the parasite 
during immune response and can cleave extracellular matrix proteins, which might facilitate 
amoebic invasion[Scholze et al. 1988, Keene 1986]. Mainly carbohydrate metabolizing, energy 
metabolizing enzymes and lyssomal enzymes are abundant and participate in amoebic –host 
liver cell interaction as shown in Figures 2,3a,3b and 3c. These proteins act as virulence factors 
in animal models of amoebic liver abscess [Stanley et al.1995, Ankri et al.1999]. A family of six 
genes encodes E. histolytica cysteine proteinases (ehcp1–6 ) but ~90% of the proteinase activity is 
related to three proteinase enzymes, EhCP1, EhCP2 and EhCP5 [Bruchhaus, et al. 2003]. 
Although targeted disruption of selected E. histolytica genes has not yet been achieved, stable 
episomal expression of foreign DNA is possible in amoebae by maintaining continuous 
selective pressure [Hamann et al. 1995, Vines et al. 1995]. This has enabled the investigators to 
target specific molecules in E. histolytica by the episomal expression of antisense mRNA or of 
genes encoding dominant negative mutants [Ankri et al. 1998]. The antisense approach has 
been applied to E. histolytica cysteine proteinases and episomal expression of an antisense 
RNA to ehcp5 could reduce total amoebic proteinase activity by 80–90% [Ankri et al. 1998]. To 
assess the role of E. histolytica cysteine proteinases in amoebiasis, in earlier study, human 
xenografts in SCID-HU-INT mice were infected with amoebic trophozoites expressing the 
ehcp5 antisense RNA(proteinase-deficient amoebae) or amoebic trophozoites containing the 
same plasmid without the antisense insert (the control group)[Zhang et al. 2000]. Major 
findings were: 1. no obvious defect was apparent in the ability of cysteine-proteinase deficient 
amoebae to inhabit and survive within the colonic lumen; 2. post-24 h after infection, cysteine 
proteinase-deficient amoeba had, in contrast to the control group, failed to induce significant 
amounts of human IL-1ǂor IL-8 from infected intestine; 3. gut inflammation was also reduced 
in human intestine infected with cysteine-proteinase-deficient E. histolytica trophozoites; 4. 
control E. histolytica trophozoites damaged the intestinal permeability barrier at 24 h but there 
was only a minimal increase in intestinal permeability in human intestinal xenografts infected 
with cysteine-protease-deficient amoeba; 5. histological studies at 24 h, human xenografts 
infected with control amoebae showed damage to the colonic mucosa, invasion of amoebic 
trophozoites into submucosal tissues and neutrophil-predominant inflammation; 6. by 
contrast, xenografts infected with cysteine-proteinase-deficient amoebae showed less mucosal 
damage, almost no evidence for amoebic invasion into submucosal tissue and little 
inflammation. Authors speculated that cysteine-proteinase-deficient amoeba might have a 
defect in their ability to induce gut inflammation and to invade into the submucosal tissues 
[Zhang et al. 2000]. How amoebic cysteine proteinases contribute to gut inflammation and 
tissue damage in amoebiasis? Possibly, Entamoeba histolytica trophozoites expressing the ehcp5 
antisense RNA might have reduced the phagocytic capabilities or reduced virulence in 
amoebiasis [Ankri et al.1998]. However, protease-deficient amoebae maintain their ability to 
lyse target cells, so a defect in cell killing does not underlie the reduced virulence of cysteine 
proteinase-deficient amoebae [Seydel et al.1997]. In addition, it is unlikely to be a direct effect 
of cysteine proteases on intestinal epithelial cells, because amoebic lysates rich in cysteine 
protease activity fail to induce high levels of cytokine production or inflammation when 
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placed in human intestinal xenografts [Ankri et al.1998]. It suggests that amoebic cysteine 
proteinases must exert their effects on gut inflammation and tissue damage after an initial step 
that requires live active trophozoites. 
1.2 Entamoeba histolytica and programmed cell death 
Other important role of caspase enzymes was explored when E. histolytica trophozoites were 
incubated with common types of mammalian cells. Normally trophozoites kill mammalian 
cells in a contact dependent manner by two processes: by lytic necrosis [Berninghausen et 
al.1997] or undergo apoptosis[Ragland et al.1994]. Apoptosis, or programmed cell death, is 
an ordered system of cell death with an initiator or signaling phase followed by an effector 
stage that causes cell death by degrading various cellular components. The effector stage 
involves the activation of caspase enzymes, cysteine proteinases with specificity for 
aspartate residues that form a cascade, converging on caspase 3. A key biochemical marker 
of apoptosis is endonuclease cleavage of chromatin between histone bodies, which can be 
seen as a DNA ladder on separating gels.  
Detection of DNA fragmentation in situ by the endlabeling of single- or double-stranded 
DNA breaks with terminal deoxyribonucleotidyltransferase (TUNEL assay) has also been 
used as a biomarker of apoptosis [Schulte-Hermann et al.1994]. However, E. histolytica can 
induce apoptosis in vitro raises doubt if apoptosis is a component of the cell death 
commonly seen in amoebic liver abscess. To test this fact, amoebae were inoculated into the 
livers of SCID mice and evidence for apoptosis was sought by gel separation of DNA from 
infected livers and TUNEL staining of amoebic liver abscesses [Seydel et al.1998]. DNA 
ladder formation was detected in samples obtained from SCID mice by 1 h after amoebic 
inoculation. TUNEL staining revealed significant areas of apoptosis within amoebic liver 
abscesses common in inflammatory cells and hepatocytes close to amoebic trophozoites 
[Stenley, 2001]. However, some distant liver cells also were TUNEL positive. Thus, in the 
murine model of amoebic liver abscess, E. histolytica induced cellular apoptosis appears to 
be a significant component of cell death as shown in Fig. 3. Interestingly, E. histolytica-
induced apoptosis was not blocked by Bcl-2 [Ragland et al.1994] and did not appear to 
involve either of the two of the major pathways for the induction of apoptosis: ligation of 
the Fas receptor and ligation of TNFǂ1 receptor 1 (TNFR1). In both C57Bl/6 MRL-lpr/lpr 
mice with no Fas receptor, and C57Bl/6.C3H-gld/gld mice with no Fas ligand, apoptosis 
was detected in amoebic liver abscesses by DNA ladder formation and TUNEL staining 
[Seydel et al. 1998]. Apoptosis was also present in hepatocytes in amoebic liver abscesses 
from both TNFR1 knockout mice and the heterozygote controls[Seydel et al. 1998].]. These 
data indicate that E. histolytica causes apoptosis in mouse liver by a mechanism that is 
independent of Fas–Fas-ligand interactions and TNFR1. 
Genetic approaches and new models of amoebic liver abscesses have provided good 
prospects on the complex interactions between E. histolytica and the host liver cells [Hamann 
et al.1995]. Well-known E. histolytica enzymes lyse cells and digest extracellular matrix 
proteins. Enzymes have capability to induce apoptosis in hepatocytes and inflammatory 
cells. Enzymes can stimulate, and perhaps enhance, an NF-κB-mediated human liver 
inflammatory response that contributes to tissue damage. These new enzyme regulated 
pathways might offer an explanation for some of the clinical and pathological differences 
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between amoebiasis and amoebic liver abscess. The hepatocyte inhabited apoptosis would 
predominate in amoebic liver abscesses. If these mechanisms prove to be important in 
human disease, they will provide new targets in both the host and the parasite for 
interventions designed to ameliorate or inhibit amoebiasis and amoebic liver abscesses. 
Recently, author in team established that apoptosis results with hypoxia in liver cells and 
evaluated nitroimidazole cytotoxicity [Kwon et al. 2009]. In following section, a criterion of 
hepatocellular hypoxia is described based on liver cell enzymes and cytomorphology.  
 
Fig. 1. Entamoeba histolytica trophozoites induce apoptosis in inflammatory cells and 
hepatocytes in amoebic liver abscesses. Section of liver stained for apoptotic cells with the 
TUNEL method from an amoebic liver abscess in a C57Bl/6 MRL-lpr/lpr mouse. Amoebic 
trophozoites (long arrow) are adjacent to a cluster of inflammatory cells (short arrow), 
which show marked TUNEL staining. TUNEL staining in nuclei and cytoplasm is also 
evident in a band of dead hepatocytes and inflammatory cells (D). TUNEL-positive nuclei 
(brown staining) are also visible in hepatocytes in regions (H) flanking the dead cells. 
Reproduced, with permission, from Ref. Seydel et al. 1998. 
2. Liver enzymes and enzyme inhibition in human liver: Hepatocellular 
criteria  
The liver is made of parenchymal hepatocytes and nonparenchymal Kupffer cells as sole 
targets that exhibit their intracellular biochemical changes as hepatocellular enzyme 
biomarker profile. Liver cells are rich in enzymes. Enzyme inhibition in liver is characterized 
by two ways: 1. intact hepatocellular enzymes in hypoxia serum and liver homogenates; 2. 
Enzyme regulatory behavior by characterizing enzymes in presence of additives added to 
cultures of isolated liver cells. Additives and drugs are mainly biotransformed and 
detoxified in liver by a battery of drug metabolizing enzymes: lysosomal and microsomal 
enzymes. Drugs inhibit enzymes. In following description, readers are introduced with the 
importance of enzyme inhibition as research tool for two purposes: 1. drug testing and 
hypoxia disease monitoring (Hepatocellular Hypoxia Criteria) to understand the hypoxia 
and liver cell interactions with amoeba and nitroimidazole; 2. Enzyme regulatory behavior 
in presence of additives in isolated liver cells in culture (hepatocytes and Kupffer cells).  
2.1 Hepatocellular hypoxia criteria  
Author proposed a “Hepatocellular Hypoxia Criteria”. ‘Hepatocellular hypoxia criteria’ 
assumes that initially liver cells loose metabolic integrity (ATP and NADPH insufficiency 
from glucose to cause oxygen insufficiency in mitochondria) and undergoes apoptosis 
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followed by detectable necrosis in liver. Hypothesis was that liver cells undergo a series of 
changes - hepatocytes undergo metabolic energy loss and oxygen depletion (hypoxia) while 
Kupffer cells undergo phagocytosis, respiratory burst and proteolysis. Nitroimidazole 
induces enzyme inhibition in liver cells to normalize the elevated enzymes during metabolic 
energy loss and oxygen depletion (hypoxia) in liver cell (in mitochondria) and lysosomal 
enzyme inhibition to combat the phagocytosis. The approach is applicable possibly in 
design of drugs to treat oxygen starved tumor cells or infected liver lesions and abscesses.  
Previous reports on first initial stage of nitroimidazole induced liver cell cytotoxicity 
indicated the apoptosis, glutathione, DNA interaction, oxygen depletion, lactate inhibition, 
enhanced NADPH cytochrome reductase and superoxide dismutase enzymes [Ersoz et 
al.2001, Brezden et al.1997, Noss et al.1988, Sugiyama et al.1993, Berube et al. 1992, Sapora et 
al.1992, Moselen et al. 1995, Stratford et al.1981, Adams et al.1980, Noss et al. 1989, Mulcahy 
et al.1989, Widel et al. 1982, Rauth et al. 1981, Chao et al. 1982, Whitmore et al.1986]. Still 
nitroimidazole structure-function relationship between hypoxia, radiosensitization and 
cytotoxicity or liver regeneration remain less understood perhaps due to nitroimidazole low 
sensitivity to clinical investigations and significant enzyme alterations only at the very late 
necrotic stage [Cowan et al.1994, Melo et al. 2000, Moller et al. 2002, Ballinger et al. 1996, 
Edwards et al. 1981, Edwards et al.1982, Ballinger et al.2001, Riche et al.2001, Melo et 
al.2000]. However, nitroimidazole cytotoxicity was reported continuously in last three 
decades indicating many altered enzymes involved in nitric oxide production, cytokines, 
oxygen depletion (hypoxia) and immunoactive substance release from both hepatic 
infections and cancer tumor tissues [Su et al.1999, Rumsey et al.1994, Koch et al.2003, 
Hodgkiss et al.1997, Sharma 2009a, Sharma et al.2009b]. In following section, author puts an 
evidence of hepatic metabolic integrity loss (in mitochondria and cytoplasm) and lysosomal 
stimulation associated with hypoxia in liver. Nitroimidazole is still considered clearly 
hepatotoxic, renal and neurotoxic drug with several reports of diffused damage of 
parenchymal and nonparenchymal liver cells as initial stage of hepatic damage observed by 
electron microscopy and biochemical markers in serum with emphasis of pathophysiology 
[Mahy et al.2004]. Our previous observation on nitroimidazole induced effects to act against 
hepatic amoebiasis and amoebic abscess development indicated the possibility of 
nitroimidazole concentration-dependent effects upon oxygen depletion, nitric oxide 
production, cytokine synergy and liver cell enzyme alterations as inter-related consequences 
of liver regeneration or bringing back elevated enzyme levels [Chu et al.2004]. The major 
players were the energy metabolizing and drug metabolizing lysosomal enzymes in initial 
liver damage with assumption that liver cell enzyme profile defines the hypoxia sensitivity 
of nitroimidazole by ‘Hepatocellular Hypoxia Criteria’. The novelty of hepatocellular 
hypoxia criteria was detail cytomorphic-biochemical information extracted from altered 
enzyme activities during initial cytomorphic changes in hypoxic hepatic cells 
simultaneously with microstructure changes by electron microscopy to confirm the role of 
cell organelle in hypoxia development. The criterion can be used to evaluate common liver 
hypoxia conditions such as hepatic tumors, hepatic infections etc. Several new 
nitroimidazole derivatives are emerging as potential cancer chemosensitizers, hypoxia 
markers and hypoxia imaging contrast agents acting as enzyme inhibitors [Gronroos et 
al.2004, Ziemer et al.2003, Jankovic et al. 2006, Papadopoulou et al.2003, Eschmann et 
al.2005, Heimbrook et al.1988, Berube et al.1992, Sharma et al. 2009].  
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Components of Hepatocellular Hypoxia Criteria: The criterion is described a step by step 
sequence of oxygen depletion in hepatocellular damage: 1. initial loss of metabolic integrity; 
2. programmed regulatory failure of cell oxygen and energy metabolism; 3. liver tissue 
inflammation and immunity loss; 4. necrosis and active death. The purpose of metabolic 
integrity in hepatocytes is keeping cells intact by maintaining balance between glucose 
formation and glucose breakdown to maintain energy flow of NADPH and ATP molecules. 
Sequence: The nitroimidazole induced liver cell cytotocity leads to enhanced glucose 
breakdown and more demand of ATP and NADPH. With course of time, high energy 
demand at the cost of cell metabolic resources leads to metabolic integrity loss or energy loss 
and oxygen deprivation followed by possibility of step by step programmed cell death (only 
in tumor cells). In normal liver cells, the nitroimidazole cytotoxicity effect cause less damage 
and cells sustain the effect while struggling oxygen starved infected or tumor cells further 
loose capability to stay alive (such cells die after nitroimidazole induced infected or tumor 
cell killing). In normal cells, liver regeneration recovers the damage.  
Hepatic hypoxia criterion has 3 major enzyme components: 1. major event of high glycolytic 
rate is immediate result of high glucose turnover such as glycolysis followed by secondary 
metabolic cycles viz. tricarboxylic acid, glycogenolysis, gluconeogenesis, pentose phosphate 
pathways; 2. changes in peripheral biomarkers such as cytokine immunity, altered 
glutathione reductase, nitric oxide production, super oxide dismutase enzymes; 3. after 
severe energy loss, changes occur in liver cellular morphology and tissue shrinkage [Sharma 
et al.2011, Kwon et al. 2009]. The sensitivity of different enzymes as cytomorphic 
manifestation of hypoxia in liver abscess and nitroimidazole induced liver regeneration is a 
simple scheme of “Hepatocellular Hypoxia Criteria” in steps is shown in Table 2. In 
following section, different enzymes are described. 
 
Morphological changes Clinical changes Liver biochemical changes 
1. Physical examination:   
-- abdominal pain -- 
intestinal damage fever -- 
hepatic infiltration hepatomegaly liver function tests(elevated) 
  
Loss of cellular metabolic integrity 
   
2.Electron microscopy: hepatomegaly with altered hepatocyte enzymes of: 
Mitochondria(M) diffused injury low ATP/ADP; NADPH/NADP 
endoplasmic reticulum(ER)  
 
 
gluconeogenesis 
peroxisome (P) glycogenolytic 
lysosome (L) lysosomal enzymes 
nuclear changes (N) oxygen flux related 
Hepatocellular enlargement (Apoptosis) 
Table 2. Continued 
www.intechopen.com
Mechanisms of Hepatocellular Dysfunction  
and Regeneration: Enzyme Inhibition by Nitroimidazole and Human Liver Regeneration 
 
203 
Morphological changes Clinical changes Liver biochemical changes 
3. Cellular organelle damage: poor drug response slow metabolic disorder: 
mitochondria(M)  
 
 
oxidative phosphorylation 
microsomes (MI) drug metabolizing enzymes 
lysosome (L) initial phagocytosis 
nuclear (N) DNA fragmentation(beads) 
cytosol (C) glucose/protein/respiratory burst 
Hepatocellular Oxygen insufficiency (inflammation) 
4. Liver pathology changes:  raised diaphragm  
mitochondrial damage amebic liver scan +ve stimulation of Kupffer cells 
exfoliative ER  
 
 
 
 hyperplasia of Kupffer cells 
 anisonucleosis loss of metabolic control 
autophagy & lysosomal 
irritation 
 increased water accumulation 
cytosolic granulation  increased molecule  imbalance 
 fatty liver appearance with  increased lipid synthesis 
membrane damage  
Hepatocellular degeneration and necrosis 
5. Hepatocytology:   
Cell proliferation advancing tumor 
vascularization 
 surgical aspirates (altered  
 Cell debris tissue growth on 
ultrasound 
 proteins, lipids, enzymes) 
  
Nitroimidazole single dose therapy schedule 
6. Liver cell recovery negative liver 
scan/ultrasound 
normal liver function test 
Tissue shrinkage Hypoxia monitoring 
positive 
-ve Hypoxia biomarkers 
OR    if unchanged or poor 
recovery 
abnormal ELISA,enzymes 
  
 Surgical intervention  
Source: Sharma R. Effect of Nitroimidazole on isolated liver cells in development of amoebic liver 
abscess. Ph.D dissertation submitted to Indian Institute of Technology, Delhi, 1995. 
Table 2. A step by step scheme of “hepatocellular hypoxia criteria” to evaluate liver hypoxia 
damage in infected hepatitis or hepatic tumors. Different clinical methods suggest 
composite picture of hepatic hypoxia and associated biochemical and cytomorphic changes. 
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2.2 Origin of hypoxia and enzyme regulation 
Oxygen insufficiency or hypoxia begins with low NADPH and ATP supply from glucose. 
Glucokinase, aldolase, pyruvate kinase and lactate dehydrogenase possibly serve as initial 
glycolytic regulatory enzymes for energy flow to generate tricarboxylic acid cycle (TCA) 
precursors. TCA cycle being as main source of energy molecule synthesis and 
gluconeogenesis, it serves as sole source of central ATP pool in glucose homeostasis during 
liver cytototoxicity or regenerated liver cell [Sharma et al.2007, Sharma et al.2010]. The 
citrate synthase, malate dehydrogenase, isocitrate dehydrogenase and succinate 
dehydrogenase enzymes serve as TCA cycle regulatory enzymes. These enzymes in 
hepatocytes characterize the tumor hypoxia and hepatocyte response after nitroimidazole 
therapy [Horlen et al.2000, Tabak et al.2003, Sapora et al.1992, Moselen et al.1995, Stratford 
et al.1981]. At the cost of ATP from TCA cycle and oxygen from the cell, oxidative 
phosphorylation maintains the metabolic integrity and continuous flow of energy. In the 
state of low NADPH and low oxygen cell undergoes state of metabolic integrity loss and 
“hypoxia”. NADPH dependent cytochrome redox enzymes are biomarker of oxidative 
phosphorylation status and oxygen insufficiency (hypoxia) in liver. Other glutathione 
reductase and superoxide dismutase enzymes are biomarkers of hypoxic state of liver cells 
[Larrey et al.2000, Michaopoulos et al.1997]. Any energy imbalance and oxygen insufficiency 
(hypoxia) in liver cell are indicated by these enzymes [Michaopoulos et al.1997, Ramirez-
Emiliano et al.2007]. The behavior of these enzymes in isolated liver cells is described in 
following section on isolated liver cell enzymes.  
  
Fig. 2. The liver scan (on left panel) is shown for assessing the position of hepatic hypoxia 
and associated hepatomegaly and for biopsy collection site as shown with arrow. 
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Fig. 3a. The histogram bars show the effect of nitroimidazole on biomarker enzymes and 
comparison of different enzymes in hepatocytes in control vs nitroimidazole treated subjects  
 
 
 
 
 
 
Fig. 3b. The histogram bars show the effect of nitroimidazole on biomarker enzymes and 
comparison of different enzymes in Kupffer cells in control vs nitroimidazole treated 
subjects in control vs nitroimidazole treated subjects 
Nitroimidazole 
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Fig. 3c. The histogram bars show the effect of nitroimidazole on biomarker enzymes and 
comparison of different enzymes in serum biomarker enzymes.  
3. Enzyme inhibition in initial loss of metabolic integrity, glycolysis and ATP 
in hepatocytes 
Enzymes in serum and liver cells from positive control amoebic liver abscess patients 
exhibited more or less specific characteristic changes in enzymes [Sharma et al.2008]. First 
goal was to establish elevated enzyme levels in patients and to prove subsequent enzyme 
inhibition after nitroimidazole therapy. Author reported ten control subjects with 2’-
nitroimidazole therapy follow up for their carbohydrate metabolizing enzymes in serum 
and hepatocellular enzymes in liver biopsy tissues. Proven ten hepatic hypoxia control 
subjects were studied for hypoxia by enzyme assays [Sharma et al.2008]. The 2’-
nitroimidazole treated paired ten subjects were studied for hypoxia related enzyme 
inhibition using enzyme assays and hepatocellular cytomorphology by electron microscopy. 
Out of ten positive control subjects, nine patients showed elevated carbohydrate 
metabolizing and lysosomal enzyme levels in serum: Glucokinase (in 80% samples), 
aldolase (in 80% samples), phosphofructokinase (in 80% samples), malate dehydrogenase (in 
75% samples), isocitrate dehydrogenase (ICDH) (in 60% patients) were elevated while 
succinate dehydrogenase and lactate dehydrogenase (LDH) levels remained unaltered. 
Lysosomal ǃ-glucuronidase, alkaline phosphatase, acid phosphatase enzymes showed 
enhanced levels in the all patient serum samples. In ten control liver biopsies, the isolated 
hepatocytes and Kupffer cell preparations showed altered liver cell enzyme levels. 
Hepatocytes showed reduced glucokinase (in 80%), LDH (in 80%), and higher content of 
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aldolase (in 80%), pyruvate kinase (in 100%), malate dehydrogenase (in 80%), ICDH (in 
80%), citrate dehydrogenase (in 70%), phosphogluconate dehydrogenase (in 80%). Kupffer 
cells showed higher enzyme levels of ǃ-glucuroronidase (in 80%), leucine aminopeptidase 
(in 70%), acid phosphatase (in 80%) and aryl sulphatase (in 88%). In these 10 biopsy samples 
from subjects, the electron microscopy cytomorphology observations showed swollen 
bizarre mitochondria, proliferative endoplasmic reticulum, and anisonucleosis. In 2’-
nitronidazole clinical trial patients, after 2’-Nitroimidazole effect in liver cell damage was 
manifested as enzyme inhibition in liver cells as shown in Figure 3[Sharma 2008]. 
Nitroimidazole treated patients shows altered enzymes: glucokinase levels were more or 
less normal in both serum and liver biopsy (100%); phosphofructokinase levels were 
nonspecific in nitroimidazole treated subjects or normal (80%); elevated lactate 
dehydrogenase levels were reversed to normal. In nitroimidazole treated subjects the 
elevated enzyme levels due to amoebic abscess brought back to normal after nitroimidazole 
treatment due to enzyme inhibitory effect of nitroimidazole: isocitrate dehydrogenase 
enzyme normal levels (80 %); the citrate synthase normal levels (80%); phosphogluconate 
dehydrogenase normal levels (80 %). In nitroimidazole treated subjects, the succinate 
dehydrogenase levels were normal (60 %) in both. The enzymes are shown in Figure 3 and 
Tables 2-4. 
3.1 Enzyme inhibition in Kupffer cell lysosomal enzymes and Hypoxia 
In nitroimidazole treated patients showed elevated enzymes brought back to normal: ǃ-
glucuronidase normal levels (50 %) in Kupffer cells and normal in serum (60 %); acid 
phosphatase normal levels in both; leucine aminopeptidase levels were normal in serum (80 
%) and remained high in Kupffer cells (60%); Guanase levels were normal in both Kupffer 
cells and serum (80%). The enzymes are shown in Figure 2 and Table 3. 
Kupffer cell hyperplasia was observed with swollen lysosomal contents as shown in Figure 
4. Altered glycolytic enzymes in cytosol, TCA cycle enzymes in mitochondria, lysosomes 
and increased synthesis of enzymes by endoplasmic reticulum showed correlation with 
clear liver cell degeneration of microbodies. After nitroimidazole treatment, observations of 
both electron microscopy and biochemical parameters suggested the reversed hepatocellular 
changes towards normal recovery or liver regeneration. In following section, I describe the 
outcome of nitroimidazole effect in liver regeneration and enzyme inhibition as defense. 
The enzyme biomarkers could be analyzed in serum and liver cells (hepatocytes and 
Kupffer cells) as clinically significant indicator of hepatic damage in disease or cytotoxicity 
of drug. We assume that initially metabolic integrity loss leads to over-secretion of liver cell 
enzymes including lysosomal enzymes. Soon after, the ultrastructural changes in liver cells 
become evident by electron microscopy suggestive of acute organelle degeneration. 
Ultrastructural hepatocyte cytotoxicity was associated with nitroimidazole overdosage 
(normal dosage is 2 × 3 gm one time in amoebic hepatitis and thrice in amoebic abscess). The 
regenerative changes were consistently observed after nitroimidazole therapy to reverse 
liver damage. Few pathology reports are available to show nitroimidazole cytotoxicity and 
no electron microscopy study is available to support asymptomatic inflammatory or 
unequivocal diffuse parenchymal injury exhibiting diffused sinusoidal and portal 
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infiltration events [Tabak et al.2003, Larrey et al.2000]. Biomarker liver cell enzymes with 
electron microscopy put evidence of amoebic cytotoxicity in liver biopsy samples and liver 
regeneration after nitroimidazole treatment by ‘hepatic hypoxia criteria’. Degenerative 
changes of hepatocytes suggested possible necrosis.  
       
Fig. 4. Ultrastructural changes are shown in hepatocyte organelles during hypoxia: 
exfoliation of endoplasmic reticulum (top on left); anisonucleosis (mid and bottom on left); 
intercellular junction gaps (top and mid panels in center); nuclear inclusions (bottom on 
center); swollen and bizarre mitochondria(top on right); inclusions in peroxisome (mid on 
right); mitochondrial atrophy with lipid vesicles (bottom on right). Hepatocyte 
mitochondria became swollen, bizarre with dense matrix and showed destorted cristae, 
endoplasmic reticulum dilated vesicles, giant nuclei with diffuse proliferation of 
endoplasmic reticulum and clear anisonucleosis features. The ultrastructure of liver cells 
showed characteristic organelle changes in nitroimidazole treated liver.  
Evidence of hepatic regeneration and nitroimidazole cytotoxicity (hypoxia induced changes) 
was characterized previously in terms of cytokine synergy, unusual degree of 
anisonucleosis, nitric oxide production and the presence of giant nucleus in hepatocytes 
after liver regenerative therapy [Michalopoulous et al.1997]. Endoplasmic reticulum showed 
a diffuse and intense proliferative activity in these liver cells with normal appearance of 
mitochondria as earlier reported [Ramirez-Emiliano et al.2007, Das et al.1999]. However, 
intramitochondrial inclusion bodies were absent while they were very prominent features 
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[Das et al.1999]. The cause of the ultrastructural changes after nitroimidazole cytotoxicity 
were supported by initial enzyme alterations reflecting loss of metabolic integrity probably 
induced by free radical formation from nitroimidazole [Das et al.1999]. Since ultrastructural 
changes in liver were completely reversible after nitroimidazole therapy within 7-9 days, it 
is quite reasonable that pathogenesis of diffused hepatocyte damage was due to 
nitroimidazole breakdown products.  
 
Fig. 5. The sketch of nitroimidazole induced intracellular enzyme inhibition changes 
indicating the points of metabolism and metabolic control during hypoxia and subsequent 
liver recovery after nitroimidazole treatment. The enzymes distribution in organelle and 
enzyme location in different hepatic sites explains the liver damage and enzymatic basis of 
hepatocellular hypoxia criteria [reproduced from Sharma R. 1990. Ph.D dissertation]. 
As indicated in previous section, ‘Hepatocellular hypoxia criteria’ is a sequence of events in 
hepatic cell injury at molecular level. The initial loss of hepatocellular metabolic integrity 
leads to hepatic injury. Glucose-energy metabolic integrity loss and nitric oxide formation 
with Ca++ homeostasis are main initial determinants of hypoxia [Ramirez-Emiliano et 
al.2007]. In following section, present chapter extends the enzyme regulatory behavior 
during glucose metabolizing pathways viz. glycolysis, TCA cycle and gluconeogenesis to 
establish the value of enzyme inhibition in liver regeneration. In isolated liver cells, 
metabolic alterations of energy metabolism pathways explain the events in hepatitis and 
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hepatic tumors as best correlated respective enzyme dysfunctions and ultrastructural 
changes observed in cells in biopsy. The following description is broad explanation of 
different enzymes secreted from hepatocytes as a result of nitroimidazole induced 
cytotoxicity and oxygen depletion. From biochemical stand point, different regulatory 
enzymes are discussed as biochemical events of hypoxia development as shown in Figures 
3a,3b,3c and 5. 
 
Fig. 6. The sketch of relative biomarker enzyme changes (thickness of arrow) in liver 
hypoxia. The +ve sign denotes the relative increase in enzyme activity and –ve sign denotes 
the decrease in enzyme activity in liver cells in different organelles due to ameba induced 
hypoxia. The figure sketch also represents a relative enzyme activities in sequence of 
metabolic steps as ‘hepatocellular hypoxia criteria’. Notice the liver regenerative or enzyme 
inhibitory action of nitroimidazole at different enzyme reactions is shown [Reproduced 
from Sharma R. 1995. Ph.D dissertation]. 
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3.2 Role of enzymes in energy metabolic integrity in hypoxia  
Hexokinase, a rate limiting enzyme in cytosol for glucose turnover was estimated due to 
high glucose conversion into glucose 6P showed high enzyme secretion from hepatocytes. 
Aldolase, rate controlling enzyme which splits fructose-1, 6 Diphosphate into two 3- 
phosphoglyceric acid and dehydroxyacetone phosphate, showed high enzyme secretion 
from heptocytes. Phosphofructokinase, rate controlling enzyme which phosphorylates 
fructose 6P into fructose 1, 6 DiP, enhanced as its more demand in hepatocellular glucose 
turnover which probably induced higher secretion of phosphofructokinase. Pyruvate kinase, 
transferring phosphoryl group from phosphoenolpyruvate to ADP with pyruvate 
formation, showed high enzyme secretion from hepatocytes. It may be attributed due to 
high concentration of glycolytic intermediates as terminal step was blocked or due to 2, 3 Di-
Phosphoglycerate regulated abnormal oxygen dissociation. Malate dehydrogenase and 
isocitrate dehydrogenase enzymes, catalyzing malate oxidation into oxaloacetate and 
oxidative decarboxylation of isocitrate into ǂ-ketoglutarate respectively both require NAD+. 
Both enzymes were elevated in damaged cells due to reducing equivalent low ratio of 
NADH/NAD+ pushing in forward direction. Succinate dehydrogenase, oxidizing succinate 
to fumerate using FAD, showed decreased enzyme levels due to low iron sulphur proteins 
resulting with lowered electron transport system in inner mitochondrial membrane i.e. 
supply of electrons to molecular oxygen by electron transfer from FADH2 to Fe+++ (SDH) in 
amoebic recruited liver cells. Citrate synthase, synthesizing citrate from oxaloacetate and 
acetyl CoA by aldol condensation followed by hydrolysis, showed elevated levels due to 
rapid turnover of oxaloacetate and acetyl CoA molecules during cytolysis. Moreover, high 
TCA cycle activity in hepatocyte during liver damage conditions was described earlier 
[Sharma 2010]. In serum, the enzymes exhibit their significance but aldolase, pyruvate 
kinase and LDH, MDH, ICDH observed as distinguishing the diffused injury or abscess 
formation [Virk et al.1989]. Phosphogluconate dehydrogenase elevated levels may be 
attributed due to ribulose 5P formation and transaldolase and transketolase control, for 
phosphogluconate pathway. Nitroimidazole induced cytotoxicity perhaps have insignificant 
impact on ATP supply. In following section, different enzyme regulatory behaviors of 
nitroimidazole induced enzyme inhibition are described during liver cell regeneration. A 
strategy was developed to isolate hepatocytes and Kupffer cells in monoaxenic cultures 
from excised liver samples. Mixing different inhibitors or additives in liver cell cultures 
stimulate the enzyme regulatory behavior in presence of specific growth factors, metabolite 
analogues.  
3.3 Role of lysosomal enzymes in hepatocellular damage 
In previous section, role of secretory lysosomal enzymes was described in defense of liver 
cells in context of intestinal amoebiasis and amoebic liver abscess. Conceptually, lysosomal 
hydrolases cause foreign body damage by several reactions including redox reaction, 
phosphorylation reaction, glucuronidation reaction, hydroxylation reaction, 
dehydroxylation reaction, nucleation reaction, terminal breakdown reaction, trans-
carbamylation reaction. Other studies also reported molecular mechanisms of enzymes in 
pathogenesis [Das et al.1999], liver cell damage [Virk et al.1989, Virk et al.1988], 
phagocytosis [Sharma 2009], cyclooxygenase-2 expression [Sanchez-Ramirez et al.2000]. 
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4. Enzyme inhibition properties and enzyme regulatory behavior in isolated 
liver cells 
Isolated liver cells with characteristic enzyme properties are research tools. In our 
previous study, the hepatocyte yield from livers was 2.5× 108 per mg liver. The cytosol 
fraction showed the removal of all cell organelle from supernatant and resultant 
supernatant as cytosol was free of any remnant by microscopic observation by trypan blue 
exclusion. Isolation of human Kupffer cells was developed by a modified pronase-
collagenase enzymatic isolation and purity of Kupffer cells by using biomarker enzyme 
assay. Earlier reports used similar practice of enzymatic digestion and enzymatic assays 
as indicators of cell viability and yield [Hendriks et al.1990, Neaud et al.1995, McCuskey 
et al.1990]. A new rapid method was used for the isolation and fractionation of both rat 
and human Kupffer cells without the need of liver perfusion techniques. The study used 
rat livers or small human liver wedge biopsies obtained peroperatively and incubated 
with pronase under continuous pH registration. Kupffer cells were subsequently 
separated from other nonparenchymal cells by Nycodenz gradient centrifugation and 
purified by counterflow centrifugal elutriation [Neaud et al.1995]. Identification of 
Kupffer cells was achieved on the basis of ultrastructural analyses and 
immunophenotyping [Neaud et al.1995]. The fractionation of Kupffer cells gave good 
yield comparable with other studies [Hendriks et al.1990, Neaud et al.1995, McCuskey et 
al.1990]. For details of protocol of liver cell isolation, see the Appendix in the end of this 
chapter. Human liver cell enzymes in isolated liver cells (hepatocytes and Kupffer cells in 
cultures) showed characteristic regulatory behavior in presence of additives.  
Liver cell hypoxia is represented as a state of oxygen depletion in cell. Initially liver cell 
gets its ATP and NADPH supply from glycolysis and TCA cycle. Consequently, electron 
transfer chain (oxidative phosphorylation) through series of cytochrome redox reactions 
converts available cell oxygen to water to produce high energy metabolites in the cell 
(metabolic integrity). Infected liver cells show loss of metabolic integrity and less 
available oxygen (oxygen starved or hypoxia). Nitroimidazole was established two 
decades ago as potential oxygen quenching drug in most of the infected and tumor cells. 
“Nitroimidazole oxygen quenching action” makes oxygen depleted or starved cells that 
further undergo worse to die and leaving normal cells fully functional that can be 
observed as potential tumor hypoxia therapy and antiparasitic treatment by 
nitroimidazole. 
In following section, enzyme inhibition characteristics in energy metabolism regulation 
including glycolysis, TCA cycle regulatory enzyme behavior and drug metabolizing 
proteolytic lysosomal enzymes induced by additives in liver cell cultures are described. 
4.1 Glucokinase  
The actinomycin D showed non-significant inhibitory change in glucokinase enzyme 
activity as shown in Figure 7 at the top histogram bars. The nitroimidazole showed 
enhanced glucokinase activity and reversed the inhibitory effect of actinomycin D. The 
glucokinase activity in hepatic abscess hepatocytes did not show any significant effect of 
nitroimidazole. Overall actinomycin D alone did not show any change in glucokinase 
enzyme activity in hepatic abscess hepatocytes or nitroimidazole treated hepatocytes.  
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The addition of triamcinolone with insulin in combination showed significant increase in 
glucokinase activity in all hepatocyte groups. It pointed out to the enhancement in hormone 
dependent glucokinase enzyme synthesis in hepatocytes and enzyme activity showed highest 
enzyme synthesis rate in hepatic abscess recruited hepatocytes while nitroimidazole treated 
hepatocytes showed lesser increase in hormone dependent glucokinase in comparison with 
hepatocytes as shown in Figure 7. The increase in enzyme activity or enhanced glucokinase 
enzyme synthesis in hepatocytes showed that glucokinase enzyme behavior was hormone 
dependent. Different concentration of insulin and progesterone hormones further indicated 
the regulatory behavior of glucokinase enzyme as hormone dependent. 
The addition of progesterone hormone 0.1 µgm/ml in hepatocyte cultures showed 
maximum enhanced glucokinase enzyme activity and nitroimidazole treated hepatocytes 
showed less enhanced glucokinase activity but more than control hepatocyte enzyme 
activity as shown in histogram bars (see Figure 7).  
In control group, glucokinase enzyme activity in untreated hepatocytes did not show any 
chnage in their glucokinase enzyme activity in presence of nitroimidazole additive. The 
yield of hepatocytes and glucokinase enzyme activities from hepatic abscess liver biopsy 
were similar as yield of cells and glucokinase enzyme activities in untreated and 
nitroimidazole treated hepatocytes. So, it was clear that addition of actinomycin-D and 
insulin with triamicilone both enhanced the glucokinase enzyme synthesis in hepatocytes as 
shown in Figure 7 histograms bars.  
 
Fig. 7. The nitroimidazole effect on glucokinase enzyme activity in guinea pig normal and 
infected hepatocytes is shown in presence of different enzyme regulatory additives 
actinomycin D, insulin-triamcilone. Notice the enhanced effect of insulin-triamicilone on 
glucokinase enzyme (P value <0.0001; r2 0.9872) in nitroimidazole treated vs liver abscess 
biopsy heaptocytes.  
added 
added 
progesterone 
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4.2 Pyruvate kinase 
The altered behavior of pyruvate kinase regulation in isolated hepatocytes from 
nitroimidazole and progesterone induced cultures showed characteristic sigmoid behavior 
in normal group but towards linear relationship at increased pH of hepatocyte culture 
media. In other words, a pH increase alters the enzyme velocity in same proportion with 
ATP concentration changes in linear manner in liver cell medium. At high ATP 
concentration, enzyme synthesis in nitroimidazole stimulated cells remained significantly 
elevated while at pH 7.0-7.4 cells did not show sudden enzyme elevation and showed a fall 
in enzyme activity as observed in normal hepatocytes (see Figure 8). The higher ADP/ATP 
ratio kept the enzyme synthesis high at pH 7.4 in progesterone while nitroimidazole 
stimulated the hepatocyte cells in cultures (see Figure 8).  
The intricacy was reported as ATP interacts with H+ and Mg++ to give complex distribution 
of many ionized and metal complex species. However, Mg++ free ADP itself has three 
subspecies viz. ADP--, ADPK--, ADPH— whose relative proportions vary with change in pH. 
Out of which ADP— happens to be true substrate of pyruvate kinase which presumably was 
utilized by hepatocytes stimulated by nitroimidazole. It further suggested the binding of 
ADP to unbound and fully bound enzyme conformations involving different groups within 
active site. The binding of ADP and ADP free conformation of enzyme did not involve 
groups that ionized within applied pH range in nitroimidazole and progesterone stimulated 
hepatocytes but binding of ADP to the fully bound enzyme conformation (cooperativity) 
involved the ionizable groups with high pK values (at pH 6.6-7.4). Moreover, phosphoenol 
pyruvate bound enzyme ionization has been previously reported to promote cooperative 
binding of ADP in diseased cell. In present study, ADP binding becomes less cooperative by 
stimulated hepatocytes. It is possible that enzyme may have two active conformations. So, 
allosteric interactions actually might have altered the mode of ADP binding in normal cells 
while they were non-effective in pyruvate kinase enzyme of stimulated hepatocytes. 
Pyruvate kinase active site conformation perhaps seems to change the ADP binding.  
 
Fig. 8a. The pyruvate kinase enzyme activity in control, amoebic liver abscess and 
nitroimidazole treated hepatocytes is shown in presence of different enzyme regulatory 
additives (A-I).  
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Fig. 8b. The pyruvate kinase enzyme activity in control, amoebic liver abscess and 
nitroimidazole treated hepatocytes is shown in presence of different enzyme regulatory 
ADP additives (2-5 mM ADP).  
 
 
 
Fig. 8c. The pyruvate kinase enzyme activity in control, amoebic liver abscess and 
progesterone treated liver cells is shown in presence of different enzyme regulatory 
additives (ATP, PEP+FDP,PEP inhibitors).  
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Fig. 9. The effect of nitroimidazole on phosphofructokinase enzyme activity of isolated 
hepatocytes from control, amebiasis and nitroimidazole groups. Hepatocytes from each 
group were sedimented and homogenized in Kreb Hanseleit buffer pH 8.0 containing 2.5 
mM dithiothretiol, 0.1 mM EDTA and 50 mM NaF for 90 seconds followed by centrifugation 
at 27000 g for 10 minutes. One unit enzyme activity catalyzed 1 micromole fructose 6 
phosphate to fructose 1,6 DiP per minute per mg enzyme protein.  
4.3 Phosphofructokinase 
Phosphofructokinase enzyme regulation in isolated hepatocytes cultures added with 
amoebic trophozoites, nitroimidazole and progesterone exhibited specific regulatory 
behavior. Addition of fructose 1,6 Diphosphate additive exhibited a stimulation of 
phosphofructokinase activity (see Figure 9). The effect of progesterone was seen as best 
response at 10 nM in hepatocytes of all groups while fructose 1,6 diphosphate showed 
maximum effect at concentration of 10 nM on the hepatocytes in presence of trophozoites 
added in hepatocyte cultures. However, hepatocyte cultures in other groups did not show 
any alteration (see Figure 9). Similarly, progesterone addition to hepatocytes in presence of 
trophozoites exhibited maximum fructose 1,6 diphosphate in the medium. The addition of 
progesterone concentration was within the physiological range (see Figure 9). Progesterone 
was presumed to effect enzyme activity by influencing intracellular level of various 
allosteric effectors of enzyme. Fructose 1,6 diphosphate acts as potent activator of enzyme 
activity. The phosphofructkinase enzyme activity was reported as cyclic AMP dependent 
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[Pilkis et al.1979, Sanchez-Martinez et al.2000]. However, nitroimidazole added hepatocytes 
did not respond or responded slow after progesterone addition.  
4.4 Phosphodiesterase 
Cyclic AMP dependent phosphodiesterase regulation over prostaglandin E2 and F2 
synthesis was stimulated in Kupffer cells added with trophozoits and nitroimidazole. 
Phosphodiesterase activity in Kupffer cells was dependent upon calcium ion concentration 
which was regulatory factor for cyclic AMP pool and prostaglandin production. In amoebic 
trophozoite added cultures, cells exhibited insignificant elevated enzyme activity while 
nitroimidazole addition did not alter the enzyme activity as shown in Figure 10. The 
enzyme behavior was similar in nature for its dependence on cyclic AMP secretion, 
prostaglandin synthesis and calcium ion. However, tropozoites stimulated more cyclic AMP 
secretion and prostaglandins. It provides the probable mechanism of trophozoite stimulated 
macrophagal action. Earlier calmodulin dependent adenylate cyclase and phosphodiesterase 
regulation for cyclic AMP pool have been described [Hidi et al.2000]. Moreover, the 
stimulated prostaglandin synthesis was described as calmodulin dependent cyclic AMP 
regulated mechanism [Hidi et al.2000]. Thus it seems that amoebic trophozoite addition 
with hepatocytes regulates intracellular calcium ion concentration which controls 
prostaglandin synthesis via phospholipid and arachidonic acid precursors in hepatocytes. 
Thus synthesized prostaglandins regulate the cyclic AMP intracellular levels. The similar 
mechanism has been described as “self-limiting” mechanism [Martina et al.2006].  
 
Fig. 10. Cyclic AMP dependent phosphodisesterase activity and secretion of prostaglandin E2 
and F2 in isolated kupffer cells from different groups. The phosphodiesterase enzyme activity 
in amebic liver abscess group showed highest enzyme activity after additives were added.  
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4.5 Enzyme inhibition in respiratory burst of liver cells 
An initial evidence of liver cell survival at different oxygen pressures is shown in Figure 11 
to highlight respiratory burst of enzymes. The inhibited enzymes related with cell 
respiration are presumably considered responsible of induced respiratory burst (hypoxia) in 
liver cells. Respiratory burst process including enzyme alterations (superoxide dismutase, 
glutathione reductase, NADPH oxidase enzyme activity) was suggested as initial Kupffer 
cell stimulation or respiratory burst by additives and followed by energy and oxygen 
depletion as possible cause of hypoxia and cell viability loss as important findings in 
following section.  
 
Fig. 11. Effect of oxygen supply (shown in different pressures) to liver cells. Notice the low 
oxygen supply depletes the oxygen content in cells while high oxygen supply keeps cells in 
in good survival. For long survival, reoxygenation of cells is needed(see green vertical line). 
4.6 Superoxide dismutase enzyme activity in respiratory burst of Kupffer cells  
The superoxide dismutase enzyme activity in isolated cells was comparable and showed 
minimal difference in both control and additive triggered Kupffer cells. Addition of sodium 
cyanide concentration showed small effect on elevated superoxide dismutase activities in 
both control and nitroimidazole triggered Kupffer cells. However, Kupffer cells showed 
elevated respiratory burst activity significantly high after adding 10 nM sodium cyanide in 
the cell culture medium as shown in Figure 12. However, the response of Kupffer cells with 
sodium cyanide addition was more in trophozoites added cell cultures at 10 mM sodium 
cyanide concentration. Zymosan stimulation on superoxide production was insignificantly 
high in the Kupffer cells in both groups. Earlier stimulation of zymosan induced superoxide 
anion production in Kupffer cells by sodium cyanide was reported to show the effect of 
cyanides on cytosolic superoxide dismutase enzyme activity [D'Alessandro et al.2011, 
Shahhosseini et al.2006]. Moreover, zymosan stimulated superoxide production was 
reported in Kupffer cells as reaction of cytochrome C reduction [Duan et al.2004]. 
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Fig. 12. The enzyme activity was estimated in Kupffer cells cultures added with sheep 
erythrocytes, trophozoites, nitroimidazole. The Kupffer cells were maintained for 48 hours 
or more to determine superoxide anion production in presence of 1.0 mM and 1.0 mM 
sodium cyanide additive added in culture medium. In brief, 3 x 105 Kupffer cells were 
suspended in Kreb’s Henseleit buffer containing 5 mM glucose, 3 mM calcium chloride pH 
7.4 in presence of 50 M ferricytochrome in total 1.0 ml reaction mixture and cells were 
incubated for 15 minutes in presence of different sodium cyanide additives. The reaction 
was started by addition of zymosan 500 g per ml to the medium after 10 minutes at 37 C 
supernatant was taken, centrifuged at 8000 x g in cold for two minutes and assayed for 
cytochrome C reductase enzyme activity. Ref. Sharma, R. et al. 2010.  
The O2 superoxide anion radical production as result of respiratory burst activity showed 
proportionate elevated enzyme activity in isolated Kupffer cells from cultures added with 
trophozoites and nitroimidazole additives. The active role of reactive oxygen species and 
superoxide dismutase activity in cultured Kupffer cell damage during hypoxia is shown in 
Figure 12. Previous study supported these observations on cellular damage and cytotoxicity 
from reactive oxygen species from superoxide anion acting as a scavenger [Sharma et 
al.2010]. Another possibility of Kupffer cell toxicity by additives may be associated with 
cytokines, specifically TNF-ǂ which was associated with the cytotoxicity [Sharma et al.2007]. 
Previous study also reported a decreased hepatocyte cell viability associated with altered 
cAMP phosphodiesterase and HMP shunt activity as a result of hypoxia [Carre et al.2010]. 
Authors suggested that the oxygen insufficiency is possibly a consequence of energy 
depletion and increased oxygen reactive species [Keeling et al.1982]. Other reports support 
this view of vasodilatory sensitive ATP depletion in Kupffer cells [Ana et al.2011]. The 
reactive oxygen species production also seems as another cause of hypoxia as suggested by 
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the nature of superoxide dismutase as additive cyanide sensitive enzyme. We observed a 
good reason of association between superoxide anion scavenger, glutathione reductase and 
NADPH oxidase as cause of cell viability loss leading further to Kupffer cell damage. In this 
direction, ample evidence supports the possibility of activation of HMP shunt due to 
depleted ATP and NADH in the Kupffer cells [Grahm, 2000; Spolarics et al. 1991].  
4.7 HMP shunt pathway in respiratory burst 
Hexose monophosphate shunt activation during respiratory burst in isolated Kupffer cells 
exposed with amoebic trophozoites and nitroimidazole showed enhanced enzyme activities 
as shown in Figures 13A-13C. HMP shunt activation is measured in three ways: 1. HMP 
shunt activity in presence of additives such as latex, sheep erythrocytes, trophozoites; 2. 
HMP shunt activity as radiolabeled glucose conversion to carbon dioxide; 3. HMP shunt 
activity as enzyme inhibition.  
a. The HMP shunt activity was maximum and it elevated in Kupffer cells after incubation 
with sheep erythrocytes and trophozoites while Kupffer cells exposed with inert latex 
particles did not show any activation or change in HMP shunt activity. Sheep erythrocytes 
and trophozoites both stimulated glucose metabolism via hexose monophosphate shunt 
activity. Perhaps latex particles being biologically inert nature could not change the 
cellular activity at all. So, latex particles were phagocytosed without altered HMP shunt 
activity. It suggested that HMP shunt activity may be a triggering event in Kupffer cell 
activation dependent not solely upon intracellular fate of ingested material or particles. 
However, other additives such as zymosan, erythrocytes and trophozoites also showed 
same response. Previous study reported similar response of zymosan stimulated and 
iodoacetate inhibited Kupffer cell glucose-6-phosphate dehydrogenase and 
phosphogluconate dehydrogenase enzymes.[Sharma et al.2010]  
b. The HMP shunt activity as [14C] glucose conversion to [14C]-CO2 liberated product 
indicated the active inflammation elicited by macrophage response of Kupffer cells 
[Schorlemmer et al. 1999]. The HMP shunt activity in control and triggered Kupffer 
cells was measured by [14C]CO2 release in dpm from labeled [14C] glucose per minute 
per mg protein in presence of different effectors known as quenching the hexose 
monophosphates in glycolysis. The HMP shunt activity was similar with no difference 
(P value > 0.001) in control compared with triggered Kuffer cells with effector and inert 
latex particles did not alter the HMP shunt activity. The HMP shunt activity was 
significantly enhanced in triggered Kupffer cells in presence of trophozoites (P value < 
0.001) but the HMP shunt enhancement was lesser in presence of erythrocytes. It 
indicated the dependance of HMP shunt activity on nature of effector either inert or 
surface active. The latex was inert, erythrocytes were nonvirulent and trophozoits were 
virulent as a result HMP shunt activity was enhanced in the order of latex < 
erythrocytes < trophozoits added in the medium of Kupffer cells.  
c. The trophozoites further activated the Kupffer cell glucose-6-phosphate and 
phosphogluconate dehydrogenase enzymes in association of HMP shunt activity. In 
following section, enzyme inhibition in liver cells is reported in control, hypoxic cells in 
different groups. Hexose monophosphate shunt activation was enhanced during 
respiratory burst in isolated Kupffer cells in amoebic trophozoits and nitroimidazole 
added cultures. In the cultures added with trophozoits and nitroimidazole both, 
Kupffer cells exhibited significantly elevated HMP shunt activation. The HMP shunt 
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activity was highly elevated in all groups cultures incubated with sheep erythrocytes 
and amoebic trophozoits while cells with latex particles did not show any activation. 
Perhaps latex particles being biologically inert could not change the cellular sinusoidal 
function activity. Sheep erythrocytes and trophozoits perhaps stimulated the glucose 
metabolism via hexose monophosphate pathway but latex particles were phagocytosed 
without altered shunt activity. It suggested that HMP shunt may be a triggering event 
in Kupffer cell activation dependent not upon intracelllular fate of ingested material or 
particles [Knook et al. 1980]. The trophozoits added Kupffer cells showed direct 
interaction with increased glucose-6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase enzyme activities as described as a result of 
enhanced hexose monophosphate shunt activity. Earlier zymosan stimulated and 
iodoacetate additives inhibited Kupffer cell glucose 6 phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase activities have been reported [Heuff et al. 1994].  
 Inhibition of Glutathione Reductase enzyme activity in respiratory burst: The 
glutathione reductase GSH specific enzyme activity was measured in hypoxic 
hepatocytes in presence of different GSH enzyme inhibitors such as DEM, antimycin, 
BSO as additive effectors. To demonstrate the dependence of enzyme activity on 
exposure time of inhibitors, the hypoxic hepatocytes were incubated in presence of 
effectors and enzyme activity was measured in medium. At 0 hour, the enzyme specific 
activity was same in hepatocytes in all groups. After 24 hours, the activity in 
hepatocytes was inhibited maximum by actinomycin while DEM and BSO inhibited the 
enzyme at similar extent and hypoxic hepatocytes exhibited no difference in enzyme 
activities (P value > 0.001) (see Figure 14). After 48 hours, the GSH enzyme activity was 
inhibited maximum by addition of BSO and minimum by antimycin in cell cultures. 
However, the behavior pattern of enzyme inhibition by DEM and BSO was similar. 
After 72 hours, the inhibition pattern of GSH enzyme activitity by inhibitors was same 
as after 48 hours. After 96 hours, all inhibitors showed maximal inhibition and hypoxic 
hepatocytes showed same specific activities in all groups. Antimycin inhibitor exhibited 
lesser inhibition activity of hypoxic GSH enzyme initially during 24-48 hours. 
 Inhibition of NADH oxidase in respiratory burst: The respiratory burst activity was 
described as increased activity in liver macrophages during hepatic cell damage 
showing increased oxygen consumption, stimulation of HMP shunt and elevated 
superoxide production with activated membrane NADPH oxidase enzyme as one of the 
mode of phagocytosis [Dusting et al. 2005]. Moreover, our experiments suggested the 
specific roles of additives on respiratory burst biomarkers: 1. The increased sodium 
cyanide concentration showed stimulation of superoxide dismutase activity; 2. The live 
erythrocytes and trophozoites showed HMP shunt stimulation while inert latex 
particles showed no effect on HMP shunt activity suggesting the association of additive 
nature as determinant of the HMP shunt activity or trio-enzyme inhibition; 3. The 
glutathione plays a critical role in surviving Kupffer cells during hypoxia and indicates 
the stimulated reactive oxygen species in respiratory burst activity [Bhatnagar et 
al.1981]. All these respiratory burst biomarker activities showed dependence on the 
nature of additives in corroboration with earlier reports [Kumar et al.2002; Forman et al. 
2002; Ding et al. 1988]. In present chapter, both HMP shunt activity and respiratory 
burst activity (superoxide dismutase, glutathione reductase, NADPH oxidase enzyme 
activity) are outlines for suggested initial Kupffer cell stimulation by additives and later 
followed by energy and oxygen depletion as possible cause of hypoxia and cell viability 
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loss as important finding. However, association of Kupffer cell stimulation and hypoxia 
is not conclusive and needs further investigation.  
 
 
Fig. 13. Hexose monophosphate shunt activity is shown in isolated Kupffer cells from ameba 
infected and nitroimidazole treated cells in presence of erythrocytes, trophozoits and latex 
additives (see panel on top). In 3.0 ml medium, 1 micro Curie 14C glucose was added and 
simultaneously particles added with Kupffer cells in ratio 5:1(particle:cell) for erythrocytes, 2:1 
for amebic trophozoits and 40:1 for latex. After one hour, 2 ml of cell free medium soaked by 
filter paper wetted with 100 µL of 10% KOH in counter well which further was added with 200 
µL 1.0 N H2SO4 and after 15 minutes filter paper strip elute in tritosol were measured for 
scientillation counts. The trophozoits showed maximum activity while inert latex beads did 
not show any change in activity(see panel at bottom).Ref. Sharma, R. et al. 2010. 
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Fig. 14. Effect of added stimulators on Glutathione reductase enzyme activity in hypoxic 
hepatocytes in culture. Ref. Sharma, R. et al. 2010. 
4.8 Cytochrome oxidase  
Cytochrome C oxidase was determined based upon oxidation of ferrocytochrome C by 
decrease in absorbance at 550 nm on spectrophotometer. In 3 ml reaction mixture containing 
66 mM potassium phosphate buffer pH 7.4. 20µM reduced cytochrome C and 20µl 
mitochondrial protein reaction was followed at 30°C for two minutes. Reading was recorded 
after two minutes for absorbance of completely oxidised cytochrome C by adding 0.05 M 
potassium ferricyanide. The activity of cytochrome C oxidase was expressed in n moles of 
cytochrome C oxidase/mg protein/min which is equal to concentration of cytochrome C x 
K divided by concentration of protein. For calculation of cytochrome C concentration a 
millimolar extinction coefficient of 19.1 was employed for reduced vs oxidized cytochrome 
C at 550 nm as described by Emmelot et al.1964. 
4.9 Inhibition of NADPH cytochrome P450 reductase 
Cytochrome P 450: Cytochrome P 450 was measured by spectrophotometer in absence or 
presence of carbon monoxide and determined by the method [Guengerich et al.2009]. In 
brief, 0.1 ml microsomal fraction in two cuvettes test and standard which mere added 1,5 
mg sodium dithionite and carbon monoxide passed in only test sample cuvette for 25 
seconds and same repeated again and ΔA recorded at 450 nm for cytochrome P 450 content 
in n moles per mg protein calculated by extinction coefficient 91 mM/cm path length. 
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4.10 Inhibition of adenylate cyclase  
Adenylate cyclase regulatory properties: Adenylate cyclase enzyme in isolated hepatocytes has 
been reported as tool of regulatory studies of hormones, enzymes in the presence of Gs 
bound receptors [Small et al. 2000]. Membrane adenylate cyclase activity is defined due to 
its multi-pass transmembrane protein made of two cytosolic segments as shown in Figure 
15. These segments play active roles in association of Gsǂ-GTP. The GTP induced Gsǂ 
binding with adenylate cyclase can be a key mechanism of adenylate cyclase stimulation or 
inhibition during progesterone bound ǂ-adrenergic receptor [Sunahara et al. 1997]. The 
possible mechanism of adenylate cyclase activation or inhibition by progesterone is shown 
in Figure 15. The membrane adenylate cyclase activity can be an indicator of membrane 
viability. However, the enzyme activity depends on the type and nature of effecter. The 
behavior of liver cells in culture in the presence of effectors may indicate the regulatory 
effect of stimulators in vivo. However, in cultures, hepatocytes and Kupffer cells may likely 
experience different physiological environment different from in vivo. In controlled liver cell 
culture conditions of medium, the liver cells showed adenylate cyclase stimulation in a 
specific manner by effectors such as progesterone, nitroimidazole, GTP, GITP, and 
prostaglandins [Aoshiba et al. 1997]. The receptors for prostaglandins interact with Gsǂ 
subunits. Gsǂ-GTP complex binds with ǂ-adrenalgic receptor made of seven subunits as 
shown in Figure 5. Binding of receptor with Gsǂ-GTP protein inhibits adenylate cyclase 
activity and cAMP formation. The present study highlights the behavior of liver cells and 
the characteristic features of their cyclic AMP dependent adenylate cyclase regulatory 
system in culture. 
Progesterone modulation of adenylate cyclase activity: Progesterone modulates the activity of 
adenylate cyclase and adenylate cyclase response is hormone sensitive [Gilman et al. 
1984]. The progesterone stimulates the receptor activating the adenylate cyclase by 
stimulatory Gsǂ-GTP complex resulting with formation of cAMP. Hepatocytes with 
progesterone added in medium exhibited the enhanced enzyme activity. The addition of 
GTP stimulator did not change the adenylate cyclase activity. In contrast, GITP stimulated 
cells exhibited an apparent adenylate cyclase activation. Unlike the adenylate cyclase 
enzyme activity in the presence of different effectors in stimulated hepatocytes, the rates 
of cyclic AMP production was delayed in control hepatocytes. However, progesterone 
addition to hepatocytes did not exhibit significant delay in GITP stimulated adenylate 
cyclase activity. Thus reason can be speculated that progesterone binds with stimulatory 
receptors on hepatocytes which lead to increase in intracellular cyclic AMP accumulation 
through adenylate cyclase activation via guinine nucleotide regulated mechanism [Cohen-
Tannoudji et al. 1991]. The Kupffer cells also showed similar guanine regulatory enzyme 
properties.  
The progesterone response of adenylate cyclase activity is a two phase process [Ko, et 
al.1999; Martin et al. 1987]. First, progesterone receptor and catalytic subunit (C complex) of 
adenylate cyclase occupy the place on membrane followed by Gsǂ protein interaction with 
enzyme to make G protein C complex [Ko et al. 1999]. However, the addition of GITP 
stimulated the adenylate cyclase to a greater extent in hepatocytes more than pre-exposed 
hepatocytes to progesterone. Recently, G protein-enzyme complex formation by GTP/GITP 
stimulation has been reviewed [Niu et al. 2003].  
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Fig. 15. Adenylate cyclase enzyme activity is shown in control, nitroimidazole, progesterone 
and amoebic liver abscess recruited liver cells in presence of GITP/GTP stimulators, 
protein* additives. Ref. Sharma, R. et al. 2010. 
Nitroimidazole stimulation of adenylate cyclase activity: Nitroimidazole is recently emerged as 
anti-tumor and radiosensitizer compound. It is used in tumor imaging, therapy and anti-
amoebic applications. Nitroimidazole has phenolic rings and phenolic side chains as shown 
in Figure 6. So, it is obvious that the side chains interfere with the dephosphorylation of ATP 
by phosphodiesterase enzyme. It appears to result with inhibition of hepatocyte adenylate 
cyclase catalytic subunit function in the presence of nitroimidazole. The cytotoxicity of 
nitroimidazole is poorly studied and reported. However, its anti-amoebic effect has been 
proven to decrease hepatic and intestinal infection rate. The nitroimidazole is widely 
reported as single dose in treatment of amoebic liver abscess. Moreover, nitroimidazole 
induced cytotoxic effect on human hepatocytes are still not known. DNA strand breakage, 
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energy regulatory enzymes, phagocytosis, and immune response have been reported as 
nitroimidazole induced cytotoxic effects in animals [Zheng et al. 1997; Whitaker et al. 1992; 
Singh et al. 1991]. The role of nitroimidzole is understood to restore energy regulatory 
process involving adenylate cyclase, phosphodiesterase, cAMP formation in hepatocytes 
and reported as hormone and GTP specific in action. The nitroimidazole derivatives 
inhibited anterior pituitary cell function apparently by their direct effect on the catalytic 
subunit of the adenylate cyclase holoenzyme [Stalla et al. 1989]. The nonparenchymal Kuffer 
cells play a significant role of phagocytosis sensitive to prostaglandins. Recently, 
nitroimidazole derivatives have been identified as anticancer potential agents. Still the role 
of imidazoles as anticancer agent is not established [Anderson et al. 2006]. The indicated 
study the association of imidazole ring structure with the cyclic AMP dependent adenylate 
cyclase catalytic subunit regulatory mechanism in liver cells.  
5. Inhibition of drug metabolizing enzymes in isolated liver cells  
Drug metabolizing enzymes are abundant in microsomes and lysosomes. Most of these 
enzymes are elevated or secreted at the sites of inflammation, disease conditions and in 
presence of foreign bodies. An elevated enzyme in cells and secretion from lysosomes or 
microscomes action is in defense by ‘suicide action’ of microbody against disease or foreign 
bodies. Drugs inhibit these enzymes or bring back any disease or inflammation induced 
effect on enzyme activity in liver cell. Characteristic inhibition of enzyme activities in 
different groups by nitroimidazole are shown in Figure 15. Recently, we reported the 
enzyme inhibition by nitroimidazole in detail [Sharma 2011a, Sharma 2011b]. In general, 
lysosomal enzymes are peptidases, act at acidic pH, and participate as terminal scavengers 
of harmful anions, radicals and peptides. For details, read section 2. 
Nitroimidazole inhibits the liver enzymes by making adduct for glyoxyl-glutamine 
metabolism in liver cells as author described in detail [Sharma, et al. 2011].  
6. Phagocytosis  
Although the clearance and distribution of ligand molecules in circulation represent the 
function of hepatic sinusoidal cells, these mechanisms reveal a network that is more intricate 
than would at first seem, since several receptors are common to not only one type of cell, but 
also to two or three types of cells in the liver. In the case of latex particles in which their 
uptake by a particular cell type seems to be determined by their size, sinusoidal endothelial 
cells are able to internalize particles up to 0.23 microns under physiologic conditions, in 
vivo, and larger particles are taken up by Kupffer cells. However, when the phagocytic 
function of Kupffer cells were impaired by frog virus or alcohol, the endothelial cells were 
reported to take up particles larger than 1 micron in diameter after the injection of an excess 
amount of latex particles. Endothelial cells would thus constitute a second line of defense in 
the liver in that they remove foreign materials from the blood when Kupffer cell phagocytic 
function is totally disturbed [Schoremmer et al. 1990]. This potential role may not, however, 
be fully expressed under physiologic conditions when Kupffer cells are active in clearing 
foreign substance from the circulation. The functions of liver sinusoidal cells are varied and 
complex and these cells can be regarded as "a sinusoidal cell unit." This cellular interaction 
must be taken into account for any quantitative analysis [Kampas et al. 1999]. 
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Fig. 16. Lysosomal and microsomal enzymes in isolated nonparenchymal liver cells are 
shown in control, nitroimidazole, progesterone, amoebic liver abscess recruited livers. Note 
inhibitory action of nitroimidazole on liver cells to bring normal activities in comparison to 
amoebic liver abcess recruited cells. Ref. Sharma, R. et al. 2009. 
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 Enzyme inhibition in phagocytosis: In our experiments, liver cell cultures were 
mixed with zymosan (7:1 particle cell ratio); erythrocytes (5:1 particle cell ratio); 
amebic trophozoits (2:1 particle ratio), latex (20:1 particle cell ratio) and 
nitroimidazole was added 1 µM/106 cells. Kupffer cell phagocytic activation in 
isolated Kupffer cells from human livers (added with amoebic trophozoits) was 
elevated 2-3 fold over normal Kupffer cells. Kupffer cells incubated with zymosan 
and trophozoits exhibited maximum phagocytic activity while with latex and sheep 
erythrocytes these exhibited minimum and insignificantly increased activity 
respectively. Increased phagocytic activity was time dependent which was exhibited 
by -glucuronidase, lactate dehydrogenase and plasminogen activator activity. 
Phagocytosis of zymosan and sheep erythrocytes triggered the immediate release of  
glucuronidase, stimulated synthesis of cellular lactate dehydrogenase and induced 
delayed production with secretion of plasminogen activator. Inhibition of these 
enzymes as nitroimidazole response is shown in Figures 16-18, in detail. Major 
findings were: 1. effect of nitroimidazole and latex were minimum. Similar 
observations were reported in earlier study [Kamps et al. 1999, Bhatnagar et al. 1981, 
Kuttner et al. 1982]; 2. nitroimidazole was biotransformed into water soluble products 
and cleared by drug metabolizing enzyme system of Kupffer cells; 3. latex particles 
being inert confirmed the independence of Kupffer cell activation from intracellular 
fate of ingested material; 4. amoebic trophozoits with their toxins or specific 
membrane surface signals stimulate Kupffer cells for phagocytosis resulting early 
release of lysosomal hydrolases than the release by other particles [Virk et al 1989, 
Virk et al. 1988]. However, increased lysosomal enzymes in Kupffer cells incubated 
with amoebic trophozoits were reported as a consequence of phagocytic activation 
[Froh et al. 2003]. Recently, these phagocytic activation changes due to nitroimidazole 
have been reported as associated with prostaglandin synthesis and their release 
[Spolarics et al. 1997]. 
 The glucuronidase activity showed the enhanced enzyme activity trend in all additives 
but different enzyme enhancement for different additives. In control cells, the activity 
enhanced during 24-36 hours in incubation. The erythrocytes showed most 
vulnerability to Kupffer cells in initial 24 hours. Zymosan beads showed slow response 
to phagocytosis while latex remained inert to Kupffer cells. The nitroimidazole showed 
normal enzyme pattern. It was interesting that maximum rate of phagocytosis was 
observed during 24 and 36 hours except erythrocytes. 
 Lactate dehydrogenase enzyme activity showed the enhanced enzyme activity trend in 
all additives except latex additive but different enzyme enhancement for different 
additives. In control cells, the activity enhanced during 12-36 hours in incubation. The 
erythrocytes showed most vulnerability to Kupffer cells in initial 24 hours. Zymosan 
beads showed maximum response to phagocytosis while latex remained inert to 
Kupffer cells. The nitroimidazole showed inhibitory enzyme activity in Kupffer cells 
but after 24 hours the response was stimulatory to enzyme activity (delayed enhanced 
enzyme stimulation as a result phagocytosis). It was interesting that maximum rate of 
phagocytosis was observed during 48 hours. However, the leaked out LDH activity 
represented the probable phagocytic activity of Kupffer cells relationship with time. 
Nitroimidazole addition in incubation medium perhaps showed the minimizing 
amoebic virulence [Sharma 2010]. Earlier lysosomal enzyme release with increased 
LDH cellular levels has been reported [Koppele et al. 1991].  
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Fig. 17. Phagocytic activity of Kupffer cells is shown as ǃ glucuronidase enzyme activity of 
cells after adding zymosan, erythrocytes, entamoeba histolytica trophozoits, latex beads 
additives, and nitroimidazole as drug in cultures of Kupffer cells from liver biopsy samples. 
The enzyme activity was measured after 1, 2, 3, 4 days of incubation. Each point value 
represents the average of 3 readings of observations. Ref Sharma,R. et al. 2009. 
 
Fig. 18. Phagocytic activity of Kupffer cells is shown as lactate dehydrogenase enzyme 
activity of cells after adding zymosan, erythrocytes, entamoeba histolytica trophozoits, latex 
beads additives, and nitroimidazole as drug in cultures of Kupffer cells from liver biopsy 
samples. The enzyme activity was measured after 1, 2, 3, 4 days of incubation. Each point 
value represents the average of 3 readings of observations. Ref Sharma,R. et al. 2009. 
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 The plasminogen activator induced lysis of Kupffer cells showed the enhanced 
plasminogen activity only after 36 hours. Initially the activity trend in all additives was 
same and immune to any additive added. In control cells, the plasminogen activity 
remained unaltered while kupffer cells showed immunity to zymosan and latex additives 
throughout the incubation period. However Kupffer cells showed sharp enhancement of 
plasminogen activity after 36 hours during 36-48 hours in incubation. The trophozoits 
showed maximum effect on plasminogen activator in Kupffer cells after 36 hours. 
Plasminogen activator induction has been reported dependent on de novo enzyme 
synthesis in stimulated macrophage by endotoxins and asbestos [Nagaoka et al. 2003]. 
 
Fig. 19. Phagocytic activity of Kupffer cells is shown as plasminogen activator activity of cells 
after adding zymosan, erythrocytes, entamoeba histolytica trophozoits, latex beads additives, 
and nitroimidazole as drug in cultures of Kupffer cells from liver biopsy samples. The enzyme 
activity was measured after 1, 2, 3, 4 days of incubation. Each point value represents the 
average of 3 readings of observations. Each point on graph represents the activity as extent of 
cell lysis in percent increase over basal value of 100. Ref Sharma et al. 2009. 
7. DNA synthesis in Kupffer cells 
Stimulated DNA synthesis is considered as defense mode. From physiological point of view, 
it is true that drastic change in enzymatic pattern in liver regeneration permits DNA 
synthesis. Major enzyme players are DNA polymerase and DNase (allosteric complex 
enzyme) in mitosis. We present five sequence steps of events: deoxyribonucleotides, 
ribonucleotides, DNA, RNA and proteins (see Figure 20) [Bresnick et al.1970].  
 DNase exposes 3’-OH end groups thus increases capacity of chromosomal DNA in 
vivo. DNA polymerase plays a passive role in DNA synthesis in presence of high 
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chromosomal DNA and deoxyribonucleotides. Priming DNase action on native and 
denatured DNA initiates DNA synthesis. Earlier study reported that arginase enzyme 
acts strong DNA synthase inhibitor perhaps due to lack of neosynthesized histone 
(arginine-rich histone) by reducing priming state of chromosomal DNA. DNA 
sysnthesis by means of additive or replicative DNA polymerase needs 3’-OH roup and 
polymerization proceeds from 5’-phosphate end to the growing 3’-OH end. 
 Increased RNA synthesis also increases ribonucleotide pool, rise in RNA polymerase 
activity, increase in polyamine synthesis and s-RNA methylation. The temporal 
relationship between kinetic changes in the DNA channel and the RNA channel seem to 
indicate that RNA channel is primer of DNA channel. In other words, cyclic AMP level 
may initiate both DNA and RNA synthesis beginning at the nucleotide level under 
hormonal regulation. Best example of elevated RNA sysnthesis in liver regeneration is 
elevated orotate pyrophosphorylase/decarboxylase to keep CTP/UTP pool in presence of 
UTP/CDP coenzymes for glycogenesis and lipogenesis respectively. UMP stimulated 
orotate-tRNA labeling around 18s-28s RNA complex step is preceded by an increase in 
tRNA methylation by tRNA Methylase enzyme. For its action, short chain of 
monocistronic mRNA on 18s component acts as primer for synthesis of constitutive RNA 
and export protein synthesis. Nobel Prize was awarded in 2009 on resolving the 
intricacies of ribosomal subunit interplay and consequent role of DNA/RNA Polymerase 
enzyme reactions in protein synthesis during drug induced regeneration [Schmeing et 
al.2009]. However, other enzymes RNase activity, cataionic polyamine play role in 
stabilization of ribosomal RNA (labeled methionine to spermidine) in protein synthesis. 
Increased polymine synthesis enhances ornithine decarboxylase to increase amino acid 
pool in presence of cAMP induced prostaglandins mediated growth hormone. Moreover, 
growth hormone stimulates thymidine kinase in liver. Author describes DNA synthesis in 
isolated Kupffer cells during liver regeneration after nitroimidazole treatment in amoebic 
liver abscess in following section. 
 Kupffer cells isolated from human amoebic liver abscess liver-biopsies and progesterone 
treated Kupffer cell in cultures were induced for DNA synthesis by adding 
nitroimidazole. This offered a simple model to study the mechanism of cell DNA 
induction and interdependence between two cell populations. Earlier such interactions 
between cells were reported regulated by thymidine kinase (thymidine pathway) and 
ribonucleotide reductase (thymidylate pathway)[Bresnick et al.1970]. Conceptually, 
immediately after disease in regeneration, liver cell gets confronted a challenge of 
increased protein synthesis for cell division involving metabolic enzymes leading to DNA 
synthesis (binding of ribonucleotides with deoxyribonucleotides). Two pathways play 
role in this process by Thymidine pathway and thymidylate pathway. Thymidylate 
pathway for DNA synthesis needs dTTP supply, thymidine kinase, TDP kinase to keep 
TMP pool. Basically, a repressor molecule (thymidine) inhibits transcription of thymidine 
kinase by allosteric regulation. Thymidine kinase is a TTP insensitive dimeric form (one 
catalytic site and other allosteric site) means Km for enzyme decreases with elevated ATP 
concentration (ATP positive effector and TTP negative effector). dimeric form and shows 
sigmoid behavior of thymidine kinase [Barroso et al. 2005]. Activation of thymidine kinase 
also depends on cyclic AMP activated protein kinase. On other side, ribonucleotise 
reductase reduces CDP in presence of dCMP deaminase to make dUMP (a substrate for 
thymidylate synthesis) by thymidylate sysnthetase in presence of N5,N10 hydroxymethyl-
FH4. dCMP is good enzyme inhibitor of thymidylate sysnthetase and activator of folate 
reductase to keep net high TMP pool. Ribonucleotide synthesis is regulated by 
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ribonucleotide reductase. Increase in CTP build up dCTP, purine deoxyribonucleotides 
and TTP pools[Cheung et al.1970].  
 Several types of growth factors have been reported as regulatory substances participating 
in liver regeneration process. Stimulation of DNA synthesis in Kupffer cells by amoeba 
trophozoites is shown here as response induced by colony stimulating factor. Since 
measured increase of radio label uptake by increasing amoeba trophozoite concentration 
in medium reflected an increase of cell number entering into S phase rather than higher 
rate of [3H] TdR incorporation seen in all the cells, it was possible that different Kupffer 
cells normal or pretreated with amoeba (from these different liver cell populations) may 
vary in susceptibility to colony stimulating factor (CSF). High concentrations of amoeba 
caused a reduction of thymidine uptake and remarkably reduction was measured on 
whole cover slip scintillation counts. It reflected lower incorporation of [3H] TdR into each 
DNA synthesizing cells. This phenomenon may be due to reduced capacity of Kupffer 
cells uptake as a result of DNA synthesis but it requires further inhibitor study or 
presence of CSF. Thus higher concentration of amoebae trophozoites caused a reduced 
Kupffer cell uptake capacity during CSF production. 
 
Fig. 20. DNA synthesis in liver cells in culture medium is shown in presence of macrophage 
growth factor measured as cpm/flask and cpm/cover slip during 4-10 days. Notice the 
nitroimidazole induced inhibition of DNA synthesis in amebic treated cells.Source: Sharma, 
R.(1990) Ph.D dissertation.  
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8. Inhibition of liver lysosomal enzymes in protein metaboilism 
Isolated lysosomal preparations from L[1-14C] leucine (25 Ci per 100 gm wt) 
intraperitonially injected human Kupffer cell cultures exhibited percent degradation at pH 
3.0, 4.0,5.0, 6.0,7.0, 8.0 and 9.0 at temperatures 10 °C, 20 °C, 30 °C, 40 °C, 50 °C and 60 °C, in 
presence of amoebic trophozoits after 15 minutes(short lived) and 15 hours(long-lived) 
addition as shown in Figures 21. Major players in this liver regeneration process are 
ribosomes (sitting on endoplasmic reticulum), GTP (ribotide pool) and coenzymes for 
ribotide polymerase enzymes (a balance in thymidine kinase and thymidylate synthetase). 
Other enzyme inhibition is LDH-M type gets converted to LDH-H type or lactate  
pyruvate (accelerated glycolysis). In simultaneous other set of experiment, Kupffer cell 
lysosomes in presence of leupeptin, pepstatin inhibitors and nitroimidazole in 100 g, 100 
g and 50 mM per ml concentration respectively showed aryl sulphatase enzyme activity 
changes (see Figures 21,22) in the presence of 0.3 M sucrose at 37 °C for 60 minutes at pH 5.5 
in incubation mixture of Kupffer cell lysosomes and additives. Proteolysis rate and 
degradation of short and long lived proteins in isolated lysosomes from the Kupffer cell 
 
Fig. 21. Figure shows the effect of of radiolabeled [14C]-Leucine in Kupffer cultures 
represented by aryl sulphatase enzyme activity in normal and ALA recruited cells at 
different pH and temperatures. Notice the low enzyme activity in normal cells while 
maximum leucine degradation was at pH 6 and 40 °C. 
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Fig. 22. Figure shows the effect of radiolabeled [14C]-Leucine in Kupffer cultures represented 
by aryl sulphatase enzyme activity in normal and ALA recruited cells. Notice the threshold 
of leucine turnover at 40 IU in terms of enzyme activity. Control cells showed slow % 
protein degradation and low enzyme concentration. Source. Sharma 1990. Ph.D dissertation. 
cultures added with trophozoits, nitroimidazole, exhibited increased protein degradation. 
Lysosome as proteolytic component was shown to contribute for protein degradation as earlier 
various reports indicated protein size dependence [Neff et al.1990]. Proteolytic rate in isolated 
lysosomes increased several fold with decreased intralysosomal pH. However, leakage of 
hydrolytic enzymes (elevated orotate phosphorylase/decarboxylase) may cause degradation 
of extra lysosomal orotate substrates. Thus incubation time should be short. Degradation of 
short and long-lived proteins in isolated lysosomes demonstrates that after 15 minutes of [14C] 
leucine labeling, these lysosomes were active in degradation of short time labeled proteins. 
Since transit time for lysosomal enzymes from endoplasmic reticulum to lysosomes was 
around 2-3 hours [Zhu et al. 1994]. So after, 15 minutes some other proteins may be thought to 
enter lysosomes. The degradation rate in isolated lysosomes was sometimes faster for short 
time labeling because of short lived proteins as cytosolic or secretory in nature. On the other 
hand, membrane proteins had half lives in range of few days. So these long labeled proteins 
were degraded at different rates within lysosomes. Moreover short lived proteins were 
reported more susceptible to digestion by lysosomal proteases. The effect of proteolytic 
inhibitors on protein breakdown in isolated lysosomes for distinguishing lysosomal from extra 
lysosomal protein degradation was dependent upon cell type, culture medium, labeling 
schedule and inhibitors used. Inhibitors of lysosomal enzymes impede their supposed target 
of action viz. the lysosomes. But complete inhibition of proteolysis could not be possible due to 
lysosomal and nonlysosomal proteolysis. Pepstatin inhibited only selective aspartic proteinase 
cathepsin D, leupeptin inhibited thiol proteinase. Similarly nitroimidazole either 
intralysosomal pH and restored proteinases. Moreover, cathepsin D inhibition by pepstatin, 
cathepsin B, H and L inhibition by leupeptin are reported commonly [Katunuma, 2011]. Thus 
lysosomes were active in degradation of both short and long lived proteins during basal state. 
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Infected Kupffer cell lysosomes exhibited more pronounced elevated lysosomal degradation at 
pH 5.0 at temperature range 30 C-40 C as shown in Figure 23.  
  
Fig. 23. Figure shows a comparison of % proteolysis inhibition and % protein degradation in 
presence of nitroimidazole, pepstatin and leupeptin. Proteolysis is represented in terms of 
arylsulphatase enzyme activity. Notice the size of peptide length makes difference shown by * 
for long duration and short duration of reaction in each additive. Control cells showed slow % 
protein degradation and low enzyme concentration. Source. Sharma R 1990,Ph.D dissertation. 
9. Liver regeneration and role of lysosomal enzymes  
During metabolic integrity loss and resultant hypoxia state, other factors in liver cell signal the 
alarm to produce nitric oxide, release of cytokines (IFN-ǂ with IL-1ǃ or TNF-ǂ). These changes 
also trigger the sequence of Kupffer cell stimulation and lysosomal action simultaneously. As a 
result, lysosomal enzymes, growth factor, plasminogen stimulating factor consistently 
participate or stimulate the Kupffer cell suicidal phagocytic action (hepatic necrosis) by 
nitroimidazole analogs and previously reviewed [Michalopoulos, 1990; Thurman, 2000]. In 
drug induced hepatitis, liver lysosomal enzymes have been reported elevated as stimulation of 
hepatocellular defense apart from initiating respiratory burst and chemotaxis in liver cells 
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[Vician et al.2009]. Our study showed the associated electron microscopic observations that 
Kupffer cells accumulate around the site of hypoxia and exhibited hyperplasia condition 
showing degenerated nucleus, enlarged lysosomal vesicles [Sharma, 2009]. The enlarged 
lysosomal vesicles were further correlated by elevated lysosomal enzyme levels in serum. In 
liver biopsies, these lysosomal enzymes were significantly enhanced. Acid phosphatase, 
leucine aminopeptidase enzymes catalyzing phosphorylation and amino-peptidization, seem 
to be secreted more and suggestive of active protein degradation. ǃ-glucuronidase and aryl 
sulphatase high enzyme secretion was suggestive of continuous breakdown of aryl substituted 
and ǃ-glucuronidation reactions during cytolysis and proteolysis [Knook et al. 1981]. No 
previous data is available on liver cell enzymes estimated in liver cells isolated from liver 
biopsy of nitroimidazole treated livers in hypoxia. Our observations of enzyme inhibition in 
hypoxic liver cells are very valuable to design a nitroimidazole based radiosensitizer or drug 
for parasites, myocardial ischemia, tuberculosis, neurotoxicosis etc. Liver cell enzymes may 
extend the better biochemical explanation of complex hypoxia state at molecular level. 
However, several scattered studies on serum choline esterase, alkaline phosphatase, glucose-
6P-dehydrogenase, ornithine carbamoyl transferase, cyclooxygenase-2, lactate dehydrogenase 
enzymes have been reported significant in hepatic hypoxia or hepatic damage evaluation with 
addition of new members of enzymes [Carlson et al. 1976; Koppele et al. 1991]. Enzyme 
inhibition in liver cells is significant information to design new liver cell metabolic drug 
stimulators in detoxification, evaluation of hypoxia imaging probes, and cultivation of type of 
monoaxenic liver cell cultures (hepatocytes and Kupffer cells) with specific enzyme profile. 
There appear two main reasons of enzyme level hepatic cell recovery by nitroimidazole. 
First, altered enzyme changes were recovered by nitroimidazole therapy as drug inhibits the 
enzymes participating in energy status in hepatocytes and reduces Kupffer cell macrophagal 
activity with reduced hepatic enzyme secretion to bring back enzyme levels to normal. 
Second, regenerating hepatocytes may also regulate the normal cell recovery process and 
initialize the signaling Kupffer cells to store enough lysosomal enzymes. 
10. Role of enzyme inhibition in liver transplantation and tissue engineering 
Liver regeneration after the enzyme inhibition or loss of hepatic tissue is a fundamental 
parameter of liver response to injury. Enzyme inhibition phenomenon is recognized as 
specific external stimuli involving sequential changes in gene expression, growth factor 
production, and morphologic structure. Author sums up an account on different enzymes in 
following description: 
 Angiotensin Converting enzyme inhibition by lisinopril degrades bradykinin and 
subsequently induces liver regeneration in rats. During this enzyme inhibition process 
(liver regeneration) induces 3.4 S DNA polymerase activity in both cytoplasmic fraction 
and nuclear fractions as constant while 6 S to 8 S DNA polymerase activities in the 
cytoplasmic fraction increased 6- to 7-fold [Ramalho et al.2001; Chang et al.1972]. The 
activity of histidine decarboxylase was markedly increased in regenerating liver tissues 
put. Ornithine decarboxylase is an enzyme catalyze in polyamine synthesis. Inhibition 
of ornithine decarboxylase, histidine decarboxylase, and other amino acid 
decarboxylases, was reported in regenerating rat liver and several rat tumors.[Russell, 
et al.1969]. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity 
www.intechopen.com
Mechanisms of Hepatocellular Dysfunction  
and Regeneration: Enzyme Inhibition by Nitroimidazole and Human Liver Regeneration 
 
237 
in regenerating rat liver and various tumors. Apart from enzyme inhibition, many 
growth factors and cytokines such as most notably hepatocyte growth factor, epidermal 
growth factor, transforming growth factor-ǂ, interleukin-6, tumor necrosis factor-ǂ, 
insulin, and norepinephrine, appear to play important roles in this enzyme inhibition 
and liver response. Many reviews attempted to integrate in last three decades and 
looked toward clues to the nature of triggering mechanisms in liver and cellular 
response. [Michalopoulos et al. 1997]. The major events are signaling cascades involving 
growth factors, cytokines, matrix remodeling, and several feedbacks of stimulation and 
inhibition of growth related signals. Liver manages to restore any lost mass and adjust 
its size to that of the organism, while at the same time providing full support for body 
homeostasis during the entire regenerative process [Michalopoulos et al. 2007].  
 Recently, role of tissue engineering concept showed several advantages in liver 
transplantation. However, several factors are significant in regeneration: matrices 
design, cell mass up to whole-organ equivalents, optimized microarchitecture, cell-
adhesion peptides, growth factors and extracellular matrix molecules to the polymeric 
scaffold, hepatic enzymes in microenvironment [Mooney et al. 1992]. The use of enzyme 
characterization is very helpful in hepatocyte culture to test biocompatibility required 
for the retention of tissue-specific gene expression [Kim et al. 2000; Voytik-Harbin et al. 
1997]. Liver cell transplantation into polymeric matrices (cell-matrix-constructs) is 
emerging as routine in hospitals to meet absolute requirement of the transplanted 
hepatocytes for hepatotrophic factors that liver constantly receives through its portal 
circulation [Starzl et al. 1973]. Apart from cellular therapies, two experimental 
approaches are worth mentioning for successful clinical translation. The first “cell 
sheet” technology developed by Sasagawa et al.,2007. Ott et al. reported perfusion 
decellularization to generate whole organ scaffolds [Ott et al. 2008].  
 In previous report, investigators developed a similar perfusion decellularization method 
for the liver [Baptista et al.2009] for organ bioengineering. These bioscaffolds preserve 
their tissue microarchitecture and an intact vascular network that can be readily used as a 
route for recellularization (intact enzymes of regulatory metabolic reactions) by perfusion 
of culture medium containing different liver cell populations. Significant enzyme 
inhibition assays are used as biomarkers of liver cell viability. In following example, a 
bioengineered liver (the regenerated hepatic tissue) is shown clearly visible by the naked 
eye after 7 days in the bioreactor (Fig. 24A). Regenerated tissue was highly cellular (Fig. 
24B) and displays biliary duct structures positive for cytokeratin 19 (Fig. 24C), as well as 
clusters of hepatocytes expressing cytochrome P450 3A and albumin (Fig. 24D, E, 
respectively). Expression of endothelial cell nitric oxide synthase (eNOS) enzyme in 
seeded human endothelial umbilical vein cells (hUVECs) were also observed coating and 
spreading from vascular structures (Fig. 24F). In other approach, Uygun et al. 2010 
decellularized rat livers and repopulated them with rat primary hepatocytes, showing 
promising hepatic function and the ability of heterotopically transplanting these 
bioengineered livers into animals for up to eight hours [Uygun et al. 2010]. Bioengineered 
livers displayed some functions of a native human liver (albumin and urea secretion, 
CYP450 enzyme expression, etc) and also exhibited an endothelial vascular network that 
prevented platelet adhesion and aggregation, critical for blood vessel patency after 
transplantation. Hence, this liver regeneration technology with proper active enzyme 
functions has the potential to translate in the future into the bioengineering of human size 
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livers to offer readily available liver for drug discovery applications and for liver 
transplantation, overcoming organ shortage. 
 
Fig. 24. Human bioengineered livers are highly cellular and display some of the functions 
observed in native hepatic tissue. (A) Macroscopic appearance of a seeded liver bioscaffold 7 
days after seeding with primary human fetal liver and endothelial cells. (B) H&E showing 
broad recellularization of the bioscaffold with the formation of biliary ductal structures. (C) 
Immunofluorescence staining for cytokeratin 19 (red) showing a biliary duct formed within 
the bioscaffold with a visible lumen. (D) Immunofluorescence staining of cytochrome P450 
3A (orange) and (E) albumin (purple) showing groups of hepatocytic lineage cells 
expressing these more mature hepatic markers. (F) Immunofluorescence staining of eNOS 
(purple) showing hUVECs coating and spreading from vascular structures (arrows). All 
nuclei stained with YO-PRO1 (green) or DAPI (blue). Reproduced with permission from 
reference Baptista et al. 2010. 
11. Challenges, limitations in enzyme inhibition 
There are two major challenges. First challenge was to get enough biopsy to estimate several 
enzymes. Second challenge was to choose significant enzymes as representative of 
hepatocellular criteria. The main limitation was that the ‘hepatocellular hypoxia criteria’ was 
used in small number of human subjects. The biopsy samples for electron microscopy 
observations needs more thoroughly controlled experiments. Other limitation was that the 
enzyme estimations in serum and biopsy samples may not be perfect representative samples 
and it needs to establish the measurable and actual enzyme activities in cells. The most 
crucial issue is that hypoxia is a combination of sequence of several metabolic and 
subphysiological reactions in cells. Moreover, other inflammatory cytokines, apoptosis, 
nitric oxide production and phagocytosis are associated changes during hypoxia. It further 
needs tracer technique to track the details of hypoxia in cell.  
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12. Current developments and future prospects 
Nitroimidazoles are rediscovered antiamoebic drugs having great potential of 
radiosensitizers in diagnosis and treatment of tumors, tuberculosis, myocardial infarction, 
and hypoxia. Nitroimidazole cytotoxicity was recently capitalized in hypoxic tumor 
detection and tumor killing. Nitroimidazoles act as smart enzyme inhibitors on one hand 
and play as enzyme modulators. Liver enzyme inhibition is unique for developing drugs 
in drug discovery at molecular level. The major challenge is to explore enzyme inhibitor 
that selectively and specifically catalyzes enzyme inhibition in only abnormal or diseased 
liver cells leaving safe normal cells in acute stage of liver damage such as hepatic coma, 
threatening hepatitis, hepatic cancer. The success of enzyme inhibition mainly depends on 
intracellular physiological conditions such as pH, temperature, concentration of active 
enzyme or inhibitor, coenzyme, co-factor, enzyme substrate structural-functional 
conformation state, type of biochemical reaction such as coupled, cascade or individual 
enzyme reaction and finally regulatory enzyme behavior to control metabolism. 
Currently, art is developing in liver transplantation using cultured cells to replace 
diseased or non-functional liver cells from diseased liver. Tissue engineering has opened 
the new opportunity of using conditioned monoaxenic and monoclonal liver cells in both 
experimental and pre-clinical or clinical therapeutics in both industries and academics. 
Recently, gene therapy in liver was a great success and it will be a boom in medical 
science of detoxification or drug metabolism if and when clinically accepted. Battery of 
enzymes in hepatocytes and rate limiting enzyme regulatory behavior in presence of 
additives or inhibitors will certainly enhance better understanding of disease 
development and new drug pharmaceutical action in drug discovery. Still today, liver 
cells remain as major research tool to discover drugs in therapeutics and search of 
transplantable disease resistant liver cells because of liver as sole organ responsible of bile 
formation, detoxification and drug metabolism. Cirrhosis is a serious health hazard that 
solely requires functional liver. In future, it remains to see if molecular biology will assist 
in silencing genes ON or OFF responsible of enzyme stimulation or inhibition in liver as 
method of disease therapy and cure. The major discoveries will be discovery and better 
understanding of new growth factors, colony stimulating factors affecting enzyme 
reactions in hepatocytes and Kupffer cells as major engineered cancer resistant or 
cirrhosis resistant liver cells. In future, chip technology or silica or polymer coated 
enzyme estimation techniques may be more reliable in small sample collections or in liver 
cells with high degree of accurate enzyme estimation.  
13. Conclusion 
The 2’nitroimidazole is both antiaparasitic drug and radiosensitizer hypoxia marker in 
tumor therapy. It shows hepatocellular cytotoxicity. The ‘hepatocellular hypoxia criterion’ 
distinguishes the nitroimidazole induced hepatocellular oxygen depletion and associated 
organelle changes by enzyme levels in serum, biopsy samples and cell organelles by 
electron microscopy. Initially, glucose regulation leads to metabolic integrity loss. Later, it 
may be oxygen insufficiency and slow cell death. The 2’-nitroimidazole is drug of choice 
in hepatic infections and its derivatives are emerging choice of tumor treatment. Its action 
may be evaluated rapidly by enzyme biochemical estimations without time consuming 
drug monitoring and therapeutic assay techniques. Entamoeba histolytica, an intestinal 
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protozoan parasite can proliferate, lyse and destroy human liver cells. Within the last 
decade, new animal models of E. histolytica infection showed amoebic trophozoites cause 
intestinal disease and liver abscess. Recent studies have expanded our understanding of a 
large number of enzyme inhibition reactions in hepatic regeneration after liver abscess is 
treated by nitroimidazole as remarkable drug to kill parasites. Still interactions between E. 
histolytica and human intestine; and between E. histolytica and hepatocytes or Kupffer 
cells are not fully known. In present chapter, a scheme of enzyme changes in liver cells 
during development of amoebic liver abscess and enzyme inhibition is explored in detail 
as rehabilitative action of nitroimidazole to regenerate liver cells. Characteristics of 
enzyme regulatory behavior highlight the metabolic integrity loss, energy depletion, 
oxidative phosphorylation, fatty deposition, phagocytosis and slow cell death as main 
culprits in development of liver abscess and hypoxia. Nitroimidazole inhibits several rate 
limiting enzymes to control oxygen (hypoxia) levels and keeps balance of NADPH, ATP, 
fatty acids, amino acids and proteins. In hepatocytes, enzyme inhibition and regulatory 
behavior of apoptosis (caspases, cysteine protease); carbohydrate metabolizing 
(glucokinase, pyruvate kinase, phosphofructokinase); energy metabolism (NADPH 
cytochrome P450 Reductase, Phosphodiesterase); DNA synthesis (Thymidylate 
Synthetase) describe the process of liver regeneration. In Kupffer cells, enzyme inhibition 
of drug metabolizing enzymes (oxidoreductases, proteases, esterases, phosphatases) 
predicts the liver regeneration and recovery from liver abscess. In last decade, several 
studies reported the use of enzyme inhibition mechanisms in enhancing liver regeneration 
and recovery as tool of tissue engineering and liver transplantation. In conclusion, 
enzyme inhibition mechanisms in liver damage and regeneration explain the better 
information of liver transplantation to maintain complex liver cell environment in 
balance. Enzyme inhibition mechanisms throw a light on characterization of enzyme 
regulation in engineered liver cells, amoebic liver abscess development and desired 
design of targeted nitroimidazole analogues to treat liver abscess.  
14. Appendix 1: A protocol of hepatocellular dysfunction 
Patients: In 10 control subjects, stool, ELISA, serum and liver biopsies were collected1. Only 
proved 10 subjects free from any hepatic disease were examined for enzyme estimations in 
isolated liver cells from biopsy specimens. Other ten subjects were treated with nitroimidazole 
(Tiniba and Zil from Hindustan Lever Ltd, Bombay) therapy 2 x 5 gm one-time dose thrice at 2 
days interval. At the end of dose, liver biopsy and serum collection was done.  
 All the 10 control subjects had no clinical findings of any hepatic disease and showed 
stool -ve, ELISA -ve. All 10 showed normal liver and no abscess confirmed by 
ultrasound and liver scan. The subjects were selected of 35 ±  15 years (mean age ±  sd), 
average monthly income 1750 ± 100 INR, no hepatomegaly, no diarrhea, fever and pain. 
The subjects after nitroimidazole treatment showed induced hepatomegaly insignificant 
less than 2 cm by liver scan. The subjects with amoebiasis and amoebic liver abscess are 
not included and not shown here. 
                                                 
1The patients were studied for ongoing other research study on amoebic hepatitis vs amoebic liver 
abscess by Hepatocellular Dysfunction Criteria at Liver Unit, AIIMS. The results of hepatic damage are 
shown in Figure 3.  
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The ELISA was done by method of Prakash et al.[44]. Liver biopsy was taken by Manghini 
needle [45].  
Biochemical assays: In biopsy sonipreps and serum samples the hepatocellular enzymes 
were estimated as described elsewhere [Sharma, 2009]. All substrates of enzymes were 
obtained from Sigma Chemical Company, St Louis, USA. The estimations were done on UV 
spectrophotometer Cecil Inc. England [Sharma, 2009].  
Electron microscopy: The biopsy specimens at stored in glutaraldehyde at -20°C. For fixing 
samples were fixed in dental wax and emersed in pool of 0.1 M phosphate buffer containing 
0.1 M Ca++. The samples were cut 1 mm cube by Gillette blade. The cubes were fixed for 2 
hours in 0.2 M phosphate buffer in 4 changes at 30 minutes interval in capped vials. The 
vials were washed for 2 hours in 0.2 M phosphate buffer 4 times at 30 minutes interval in 
capped vials. The vials were post fixed in buffered 1% osmium tetroxide for 1-2 hours at 
4°C, dehydrated in cold 10% ethanol for about 5 minutes followed by dehydrations in cold 
50%, 70%, 80%, 95% ethanol for about 5 minutes each and tissues were kept at room 
temperature. Further tissues were dehydrated at 100% ethanol for 15 minutes. Electron 
Microscope PA model was used for screening hepatic cell damage by epoxy resin blocks and 
osmium tetra oxide staining [46]. 
Art of liver cell isolation and enzyme characterization 
The procedures of liver biopsy excision and preparation of liver cells were followed as per 
ethical committee of institute as described in following section [Sharma, 2009].  
Reagents Used 
The collagenase enzyme was purchased from Sigma-Aldrich, St Louis, MO and pronase 
enzyme was purchased from Boerhinger Meinheim GMbH. 
Isolation and preparation of Kupffer cells: The liver biopsy samples (6-10 grams) were 
digested with collagenase enzyme (Sigma-Aldrich, St Louis, MO) 15 mg/ml for 10 minutes 
and bottom pallet was used for hepatocyte experiments. Other remained supernatant part of 
digested liver was further digested with 2 mg/ml pronase enzyme (Boerhinger Meinheim 
GMbH) in 0.2 % Kreb’s Hansleit Buffer pH 7.4 containing 5 mm glucose and 3 mM calcium 
chloride after separation of hepatocytes. The said suspension was incubated for 45 minutes 
at 37˚C stirring 250 revolutions per minute. After incubation, the cell suspension was filtered 
through nylon sieve 79 × 79 microns and filtrate was centrifuged and washed twice with 
KHB containing 5 mM glucose and 3 mM calcium chloride pH 7.4. After centrifugation and 
final washing the filtrate was centrifuged at 350 × g in ice cold centrifuge. The settled pallet 
at bottom was washed with TC 199 medium. The number of Kupffer cells was counted on 
Naubourgh counting chamber and visibility was determined by trypan blue. 
Kupffer cell fractionation: The isolated Kupffer cells were divided in two parts. One part 
was used for Kupffer cellular enzymes and other part was used for in vitro experiments. For 
enzyme estimations Kupffer cells from freshly harvested preparations were sonicated at 
zero degree temperature in said KHB buffer in soniprep. Later these were fractionated for 
different cellular fractions as described following by methods [Alabraba et al.2007; Heuff et 
al. 1994; Kirn et al.1982]. 
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1. In refrigerated centrifuge above soniprep preparations were centrifuged at 1000 × g to 
take out cell nuclear fraction and again centrifuged at 9000 × g to take out 
mitochondrial fraction as pallet at bottom. 
2. Above supernatant was centrifuged at 23000 × g to isolate microsomal bodies fraction 
along with fraction rich in peroxisomes. 
3. The light turbid supernatant was centrifuged at 100000 × g to isolate lysosomal fraction 
as clear white pallet at bottom. Sometimes microsomes were contaminated with 
lysosomes. The lysosomal purity evaluation was used to exclude microsomes free from 
lysosomes [Wisse et al.1996]. 
Kupffer cells in cultures: The Kupffer cell cultures were maintained for 48 hours after 
isolation from pronase perfused liver biopsy samples [Brouwer et al. 1988]. The in vitro 
cultured cells were screened for trypan blue exclusion [Froh et al.2003]. The Kupffer cells 
were used for their in vitro phagocytic action upon foreign particles which were sheep 
erythrocytes, latex beads and zymosan suspended in 10 mM phosphate buffer saline pH 7.4 
at 4°C. After harvesting Kupffer cells were added in phosphate buffered saline pH 7.4 
containing 4.6 x 106 adherent cells and three ml PBS-TC 199 medium in culture flasks 
containing Kupffer cells in mediukm with particle cell ratio 1:5 for erythrocytes, 1:40 for 
latex beads and 1:4 for trophozoits. The ratio for zymosan and cell was 20:1. They were kept 
up to 48 hours or more in carbogen atmosphere (95 % O2 and 5% CO2) in desiccator with 
twice changes of medium after every 24 hours. 
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